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 Leptin, a 16 kDa protein encoded by obese (ob) gene, is secreted mainly 
from white adipose tissue (WAT). After its secretion and transport to the brain, 
leptin binds to its receptors in the hypothalamus and plays a critical role in 
energy homeostasis by increasing energy expenditure and reducing food intake. 
Many studies have been reported on the regulation of leptin signaling and leptin 
functions in variety of systems, but little is known about how leptin secretion is 
regulated, which is equally important, as dysregulation of leptin secretion leads 
to the disturbance of the homeostasis in different systems. As insulin is one of the 
most important stimulators of leptin secretion, the leptin secretory pathway and 
the signaling pathways involved in insulin-stimulated leptin secretion was first 
studied. Furthermore, the potential role of calcium, a common trigger for 
regulated secretion, in leptin secretion was investigated. 
In the present study, leptin was found to be stored in membrane-bound 
vesicles localizing predominantly in the endoplasmic reticulum (ER) and the 
plasma membrane (PM) of both primary and 3T3-L1 adipocytes. Insulin 
increased leptin secretion as early as 15 min without affecting the leptin mRNA 
level suggesting that insulin-stimulated leptin secretion might be regulated 
secretion. However, although both extra- and intracellular calcium was found to 
be required for basal and insulin-stimulated leptin secretion, calcium influx alone 
is not sufficient for leptin secretion. In addition, protein synthesis inhibitor 
cycloheximide (CHX) and ER-Golgi trafficking blocker Brefeldin A (BFA) 
treatment inhibited both basal and insulin-stimulated leptin secretion, suggesting 
that leptin-containing vesicles go through the classic ER-Golgi route and insulin 
stimulates leptin secretion by up regulating the protein synthesis of leptin. 
xvii 
 
Together, these data suggest that insulin-stimulated leptin secretion is not 
regulated secretion. 
Next, the signaling pathways involved in insulin-stimulated leptin 
secretion were investigated. The phosphoinositide 3-kinase (PI3K)-Akt but not 
MAPK pathway was demonstrated to be involved in insulin-stimulated leptin 
secretion in vitro and in vivo. Since PI3K-Akt pathway was found to be involved 
in insulin-stimulated leptin secretion, the role of calcium in Akt phosphorylation 
was examined. Akt phosphorylation was significantly attenuated when extra- and 
intracellular calcium was removed, suggesting that calcium is required for 
insulin-stimulated Akt activation. 
Taken together, leptin is mainly secreted by the constitutive secretion and 
insulin increases leptin release from white adipocytes through the PI3K-Akt 
pathway. Calcium is required for Akt phosphorylation and the subsequent leptin 
secretion. 
 












WAT has long been considered to be merely an energy storage depot with 
few interesting attributes. Lately however, this tissue has gained tremendous 
scientific attraction as the increasing prevalence of obesity is becoming a 
burgeoning public health problem. What was considered to be just a storage 
depot is now a tissue that is recognized as a vital integrator of energy 
homeostatic processes. In addition to storing and regulating fat mass, adipocytes 
are involved in a wide array of physiological processes, from blood pressure 
control, to bone mass regulation, to nutrient homeostasis. These processes are 
coordinated mainly through the synthesis and release of peptide hormones by 
adipocytes, making this tissue more of an endocrine organ (Rosen and 
Spiegelman 2006).  
 One of the main peptides released from WAT is the adipokine leptin, a 16 
kDa protein that is encoded by the ob gene (Zhang, Proenca et al. 1994). The 
discovery of leptin by the Friedman laboratory was done through positional 
cloning and since its discovery, numerous scientific strides have been made to 
elucidate the mechanisms of energy homeostasis regulated by leptin (Zhang, 
Proenca et al. 1994). Upon its secretion from adipocytes, leptin circulates and 
binds to its receptor in the hypothalamus, thereby exerting a critical role in 
energy homeostasis by increasing energy expenditure and reducing food intake 
(Pelleymounter, Cullen et al. 1995). To date, many studies have reported the 
regulation of leptin receptor signaling and the function of leptin in a variety of 
tissues, but little is known about the regulation of leptin secretion from WAT. 
Elucidating the mechanism for leptin secretion is just as important as studying 
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leptin function as a dysregulated release of leptin from adipocytes results in an 
imbalance in energy homeostasis (Farooqi and O'Rahilly 2009). 
In this study, insulin is shown to increase leptin secretion by promoting 
the constitutive leptin secretion through the PI3K-Akt pathway, and calcium is 
essential for leptin secretion as it is essential for the Akt phosphorylation. Three 
main parts of background information will be reviewed in this chapter: 
knowledge of obesity and ob gene, a summary of protein secretion process, and 
the main ideas about the leptin secretion regulation. At the end of the chapter, 
aims and strategies of the current study will be presented. 
 
1.2 Obesity and adipose tissue  
1.2.1 Obesity 
 Overweight and obesity are defined as abnormal or excessive fat 
accumulation that may impair health. The body mass index (BMI) which was 
first published by Quetelet in 1853 (Rossner 2007), is defined as a person's 
weight in kilograms divided by the square of his height in meters (kg/m
2
). It is 
now commonly used to classify the overweight status and obesity in adults.  The 
World Health Organization (WHO) defines a BMI greater than or equals to 25 as 
being overweight; and a BMI greater than or equals to 30 as obesity.  
 Some WHO global estimates from 2008 showed that overall more than 
one in ten of the world’s adult population was obese. In 2010, around 43 million 
children under five were overweight. Overweight and obesity are the fifth 
leading risk for global deaths---at least 2.8 million adults die each year as a result 
of being overweight or obese. Overweight and obesity are considered as 
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important public health problems, because they are associated with type II 
diabetes, dyslipidemia, cardiovascular diseases and even some cancers (Grundy 
and Barnett 1990). As demonstrated by WHO, 44% of the diabetes burden, 23% 
of the ischaemic heart disease burden, and between 7% and 41% of certain 
cancer burdens are attributable to overweight and obesity. Therefore, it is of great 
importance to study the mechanisms underlying obesity and finding the effective 
treatment for obesity. 
 
1.2.2 Adipose tissue 
 With the increase in prevalence of obesity, more and more attention has 
been paid to the adipose tissue. There are two types of adipose tissues: brown 
adipose tissue (BAT) and WAT. 
 
1.2.2.1 Brown adipose tissue 
          BAT is found only in mammals, and is important in both basal and 
inducible energy expenditure in the form of thermogenesis. BAT expresses 
uncoupling protein-1 (UCP-1), a 32 kDa protein found in the inner mitochondrial 
membrane, that allows dissipation of the proton electrochemical gradient 
generated by respiration in the form of heat at the expense of ATP (Cannon and 
Nedergaard 2004). Morphologically, brown adipocytes are multilocular and 





1.2.2.2 White adipose tissue       
 Most mammals have white adipose depots dispersed throughout the body. 
Some of these depots provide mechanical support such as fat pads of the heels. 
Other adipocytes exist in loose association with the skin, and have been termed 
subcutaneous fat. In addition, there are several distinct depots within the body 
cavity, surrounding the heart and other organs, associated with the intestinal 
mesentery, and in the retroperitoneum. Some of these depots, known as visceral 
fat, have been linked to type 2 diabetes and cardiovascular disease. 
       The most well-known function of WAT is to store excess energy in the 
form of triacylglycerol (TAG). White adipocytes also can break down TAG to 
generate fatty acids and release them into the circulation to supply the needs of 
most organs for fuel when glucose is limited. For centuries, adipose tissue has 
been ignored and considered to be an energy storage depot with few interesting 
attributes until obesity has become a severe disorder. 
 With the rise of the prevalence of obesity world-wide, scientific 
community has paid much more attention to WAT. Now we know that white 
adipocytes are involved in a wide array of homeostatic processes. In addition to 
regulating fat mass and nutrient homeostasis, adipocytes are involved in the 
blood pressure regulation, haemostasis, bone mass, immune response, and 
thyroid and reproductive function (Trayhurn 2005). Adipose tissue regulates 
these processes mainly through peptide hormones that are synthesized and 
released by adipocytes, namely adipokines, such as leptin, adiponectin, visfatin, 
tumor necrosis factor α (TNF-α) and others.  
The list of adipokines is constantly increasing due to the use of 
comprehensive profiling technologies such as transcriptomics and proteomics 
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(Hoggard, Cruickshank et al. 2012). The precise functions of adipokines are not 
fully understood, however, the knowledge of the roles of these factors is 
expanding rapidly. Lack of adiponectin in obesity is related to dysfunction of 
endothelia, insulin resistance, and other cardiovascular disorders (Menzaghi, 
Trischitta et al. 2007). TNF-α has been shown to be important in host defense 
and regulation of glucose and lipid metabolism (Grunfeld and Feingold 1991). 
Among all these adipokines, leptin is one of the best studied ones so far.  
  
1.3 Obese gene and leptin             
1.3.1 Discovery of ob 
 Obesity has been a focus of discussion for centuries. The study on obesity 
can be traced back to the 17
th
 century. In 1614, Santorio described his metabolic 
balance by measuring his own pulse rate, body temperature, food intake and 
excretory losses. Because of the seminal contributions to metabolic work, 
Santorio is considered to be the Father of Obesity (Bray and Bouchard 2004). 
Lavoisier is the second key person in the development of obesity study. In the 
18
th
 century, he measured human oxygen consumption and showed that 
metabolism is similar to combustion, which is the fundamental contributions to 
energy balance (Fairburn and Brownell 2002). 
 Later studies suggested that energy balance in a biological system is 
physiologically regulated and there must be a system that regulates food intake 
and maintains body weight (Adolph 1947; Hervey 1969). This premise was 
advanced by the study of Hetherington and Ranson in 1942 showing that lesions 
in the ventral medial hypothalamus (VMH) can cause obesity in rats 
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(Hetherington and Ranson 1942). The scientists at that time interpreted these data 
as that energy balance was controlled by a feedback loop in which hypothalamus 
receive peripheral signals reflecting the energy stores, and the feedback loop can 
adjust food intake and energy expenditure to maintain the homeostasis of body 
weight (Brobeck 1946; Mayer 1955). 
 According to the nature of the peripheral signals, there are several 
theories. The lipostasis theory (Kennedy 1953) believed that the size of the body 
fat is controlled by central nervous system (CNS), and the product of fat can 
interact with hypothalamus and affect the energy balance. A second theory was 
the glucostasis theory (Mayer 1955) which postulated that plasma glucose level 
was the input for hypothalamus. In addition, temperature was also a possible 
input into the hypothalamus (Brobeck 1946). The possibility that one of the 
signals among these circulates in the blood stream was first demonstrated by 
Hervey, who did the parabiotic experiments (cross circulation) on rats with 
lesions in the VMH and normal rats (Hervey 1959). The VMH-lesioned rats were 
obese as expected, however, the normal rats that were connected to the VMH- 
lesioned rats decreased their food intake and lost body weight. Thus, Hervey 
demonstrated that the VMH lesioned rats overproduced a circulating factor 
which can suppress appetite, but it was still unclear what this factor was.  
 The identification of ob and diabetes (db) mouse provides genetic tools 
for the further study of obesity. Both ob and db are recessive mouse mutations 
that cause severe obesity resulting from hyperphagia and reduced energy 
expenditure. The ob mouse was identified at the Jackson Laboratory in 1949 
(Ingalls, Dickie et al. 1950) and the db mouse was identified in 1966 (Hummel, 
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Dickie et al. 1966). The phenotypes of both mutations are very similar, 
suggesting that the encoded genes function in the same physiologic pathway. 
 Coleman and colleagues conducted parabiosis experiments pairing ob/ob, 
db/db mice to wild-type (WT) mice or to each other (Coleman 1973). When 
ob/ob mice were connected to either wt or db/db ones, they decreased food intake 
and lost body weight, which was reversed after disconnection. The counterpart 
mice were unaffected when being connected with ob/ob mice. In contrast, when 
connected to db/db mice, wt mice seldom ate and lost a lot of weight, however, 
db/db animals were not affected. These data, in combination with the previous 
study, suggested that the ob gene encoded a circulating factor produced in the 
adipose tissue that decreased food intake and body weight; and that the db gene 
encoded its receptor in the hypothalamus.  
 The introduction of positional cloning provided a means to identify the ob 
gene. Positional cloning is a method to identify genes based on a detailed 
knowledge of their position on a genetic map. In 1994, the ob gene was identified 
by positional cloning to encode a 4.5 kb RNA that was expressed exclusively in 
the adipose tissue. The gene is disrupted in the two available alleles of ob. In 
C57/Bl6J ob/ob mutation, the coding sequence is identical except for a C-T 
mutation which results in a change of arginine at position 105 to a stop codon 
(Zhang, Proenca et al. 1994). This RNA encoded a predicted 167-amino acid 
polypeptide with an N-terminal signal sequence. The signal sequence cleavage 
site is C-terminal to an alanine at position 21. The ob gene is highly conserved in 
vertebrates and the alignment of the human and mouse amino acids shows that 





 The polypeptide encoded by ob gene was identified in 1995 and was 
named leptin (derived from the Greek root ‘leptos’, meaning ‘thin’). Leptin is 
produced mainly in adipose tissue but is also expressed in a variety of other 
tissues including placenta, ovaries, mammary epithelium, bone marrow, and 
lymphoid tissues (Margetic, Gazzola et al. 2002). Leptin was shown to be a 
hormone signal of 16 kDa that regulates energy balance (Campfield, Smith et al. 
1995; Halaas, Gajiwala et al. 1995; Pelleymounter, Cullen et al. 1995). Leptin 
has a single disulfide bond which is important for its bioactivity, but has no 
consensus for N-linked glycosylation or dibasic amino-acid sequences for protein 
cleavage (Zhang, Proenca et al. 1994). It circulates in the plasma of all mammals 
tested including human and rodents (Halaas, Gajiwala et al. 1995). Leptin 
concentration in plasma is positively related to the body fat mass (Maffei, Halaas 
et al. 1995). Injections of leptin to WT and ob mice, but not db mice, reduced the 
food intake and body weight (Campfield, Smith et al. 1995; Halaas, Gajiwala et 
al. 1995; Pelleymounter, Cullen et al. 1995). The failure of recombinant leptin to 
affect food intake and body weight in db mice showed that the effect of leptin is 
specific (Halaas, Gajiwala et al. 1995). All these data proved that leptin is the 
putative signal in the negative feedback loop which maintains the energy 
homeostasis.  
 
1.3.3 Leptin receptors 
  The leptin receptor (Ob-R) was first identified in mouse choroids plexus 
by expression cloning in 1995 (Tartaglia, Dembski et al. 1995). It was shown to 
be similar to the class I cytokine family of receptors and bind leptins with 
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nanomolar affinity (Tartaglia, Dembski et al. 1995). Positional cloning of the Ob-
R gene showed that this gene encodes multiple alternatively spliced forms, Ob-
Ra, Ob-Rb, Ob-Rc, Ob-Rd, Ob-Re and Ob-Rf. All these forms share the identical 
extracellular, ligand-binding domains but they differ at the C-terminus. Four of 
the five have transmembrane domains, but only Ob-Rb (also known as Ob-RL) 
has a long cytoplasmic region containing several motifs required for activating 
the Janus kinase/signal transducers and activators of transcription (JAK/STAT) 
signal transduction pathway. The other forms lack some or all of these motifs 
(Lee, Proenca et al. 1996). 
  Mutations in Ob-R result in obesity which is identical to that of ob mice 
(Li, Ioffe et al. 1998). In C57Bl/Ks db/db, the Ob-Rb transcript contains an insert 
with a premature stop codon resulting from abnormal splicing (Chen, Charlat et 
al. 1996; Lee, Proenca et al. 1996). Expression of other splice forms is unaffected 
in this mutant. Thus Ob-Rb is essential for leptin’s effect on energy homeostasis. 
          Ob-Rb is normally expressed at high level in hypothalamic neurons and 
in other cell types, including T cells and vascular endothelial cells (Ghilardi, 
Ziegler et al. 1996; Lee, Proenca et al. 1996; Lord, Matarese et al. 1998; Sierra-
Honigmann, Nath et al. 1998). In situ hybridization results showed that the 
hypothalamic arcuate nucleus (ARC), dorsomedial hypothalamic nucleus (DMH), 
paraventricular nucleus (PVN), VMH and lateral hypothalamic nucleus (LHN) 
are principal sites of Ob-Rb expression in the CNS. All of these nuclei have been 
shown to be important in regulating body weight (Mercer, Hoggard et al. 1996; 
Fei, Okano et al. 1997). 
           Within the ARC, there are two distinct classes of neurons; one class 
expresses the peptides proopiomelanocortin (POMC) and cocaine and 
11 
 
amphetamine-related transcript (CART) which reduce food intake, whereas the 
other expresses two peptides known as neuropeptide Y (NPY) and agouti-related 
protein (AgRP) which stimulate feeding behavior (Coll, Farooqi et al. 2007; Coll, 
Yeo et al. 2008). Leptin receptors are highly expressed on the membranes of both 
types of neurons, so that leptin can reciprocally regulate these two populations. 
 The functions of the other isoforms of leptin receptors are still unclear. 
Ob-Ra through Ob-Rd may play a role in the leptin endocytosis into cells (Tu, 
Pan et al. 2007).  Ob-Ra and Ob-Rc were highly expressed in the choroid plexus 
of the blood-brain barrier (BBB) and it was proposed that they might mediate the 
transport of leptin into brain across the BBB (Hileman, Pierroz et al. 2002). In 
contrast, Ob-Re or soluble leptin receptor (SLR) was shown to inhibit leptin 
transport into the brain due to its lack of the transmembrane and cytoplasmic 
regions (Tu, Kastin et al. 2008). The physiological role of these leptin receptors 
needs further study.  
 
1.3.4 Leptin receptor signaling 
  Leptin can activate Ob-Rb and trigger multiple signaling pathways which 
are important in leptin functions and leptin resistance. The Ob-Rb has no intrinsic 
tyrosine kinase activity and therefore it recruits cytoplasmic kinases JAK2, a 
member of the JAK family of tyrosine kinases (Ghilardi and Skoda 1997). Leptin 
binding stimulates Ob-Rb dimerization and they constitutively bind to JAK2 and 
leads to JAK2 activation and autophosphorylation (White, Kuropatwinski et al. 
1997; Banks, Davis et al. 2000; de Luca, Kowalski et al. 2005). JAK2 also 
phosphorylates Ob-Rb and various downstream signaling molecules on tyrosines 
(Bjorbaek, Uotani et al. 1997; Ghilardi and Skoda 1997; Kellerer, Koch et al. 
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1997). There are three conserved tyrosine residues in the cytoplasmic domain of 
Ob-Rb that can be phosphorylated and contribute to leptin receptor signaling-
Tyr985, Tyr1138, and Tyr1077 (Tartaglia 1997; White, Kuropatwinski et al. 
1997; Banks, Davis et al. 2000). After being phosphorylated by JAK2, these sites 
act as docking sites for downstream signaling molecules (Li and Friedman 1999; 
Banks, Davis et al. 2000; Hekerman, Zeidler et al. 2005). 
 
1.3.4.1 JAK2-STAT3/STAT5 signaling pathway 
 The phosphorylated domains on Ob-Rb provide highly specific binding 
sites for src homology 2 (SH2) domain-containing proteins such as STATs. The 
STAT family members are transcription factors located in the cytoplasm in 
quiescent cells. Tyrosine phosphorylation of STATs induces homo- or 
heterodimerization, nuclear translocation, and transcriptional activation (Horvath 
2004). Leptin primarily stimulates STAT3 and STAT5 phosphorylation in the 
hypothalamus in vivo (Vaisse, Halaas et al. 1996; McCowen, Chow et al. 1998; 
Gong, Ishida-Takahashi et al. 2007). Tyr1138 in Ob-Rb is in a consensus-binding 
motif for STAT3 (Stahl, Farruggella et al. 1995). Upon leptin stimulation, 
STAT3 binds to phospho-Tyr1138 and recruits JAK2 and JAK2 will 
phosphorylate STAT3. Leptin also stimulates phosphorylation of Ob-Rb on 
Tyr1077, which binds to STAT5 and activates STAT5 (Hekerman, Zeidler et al. 
2005; Gong, Ishida-Takahashi et al. 2007; Mutze, Roth et al. 2007). Deletion of 
STAT3 or STAT5 in brain results in severe leptin resistance, hyperphagia, and 
obesity, suggesting that JAK2-STAT3/STAT5 signaling pathway is important in 
energy homeostasis (Lee, Muenzberg et al. 2008; Piper, Unger et al. 2008). 
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1.3.4.2 PI3K pathways 
1.3.4.2.1 PI3K-Akt-FOXO1 pathway 
        Leptin stimulates the tyrosine phosphorylation of insulin receptor 
substrate (IRS) proteins by JAK2 (Niswender, Morton et al. 2001). The IRS then 
recruits, phosphorylates, and activates PI3K, resulting in the production of 
phosphatidylinositol 3, 4, 5-triphosphate (PI3). PI3 activation leads to sequential 
activation of 3-phosphoinositide-dependent protein kinase 1 (PDK1) and Akt 
which inhibit Forkhead box O1 (FOXO1) and the downstream POMC expression. 
FOXO1 is a transcriptional factor phosphorylated and inactivated by Akt, and it 
acts as an important downstream mediator of the PI3K pathway (Matsuzaki, 
Daitoku et al. 2003; Kim, Pak et al. 2006; Kitamura, Feng et al. 2006).  
 There are several lines of evidence showing the involvement of PI3K 
signaling in energy homeostasis. First, mice lacking IRS2 have increased the 
food intake and became obese (Withers, Gutierrez et al. 1998). Second, inhibition 
of PI3K activity with inhibitors decreased the ability of leptin to reduce food 
intake and weight gain (Niswender, Morton et al. 2001). Third, chronic activation 
of the PI3K pathway leads to diet-induced obesity (DIO) (Plum, Ma et al. 2006). 
Fourth, constitutive overexpression of an active FOXO1 mutant in the ARC 
decreases leptin sensitivity in mice and increases food intake and body weight, 
whereas energy expenditure is decreased by hypothalamic FOXO1 activation 
(Kim, Pak et al. 2006; Kitamura, Feng et al. 2006). In contrast, knockdown of 
FOXO1 in ARC increases leptin sensitivity and decreases food intake and body 
weight (Kim, Pak et al. 2006; Kitamura, Feng et al. 2006). Thus, the PI3K-
FOXO1 pathway is proved to be critical in the regulation of energy homeostasis. 
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1.3.4.2.2 PI3K-Akt-mTOR-S6K pathway 
           PI3K also activates another downstream pathway which is involved in the 
energy balance, the mammalian target of rapamycin (mTOR)-S6 Kinase (S6K) 
pathway. Akt can phosphorylate tuberous sclerosis protein 2 (TSC2) and lead to 
the inactivation of the TSC1/TSC2 complex (Inoki, Li et al. 2002), which 
inhibits the mTOR complex 1 (mTORC1) comprised of mTOR, regulatory-
associated protein of mTOR (raptor) and G-protein β-subunit like protein (GL) 
(Gao, Zhang et al. 2002; Inoki, Li et al. 2002; Tee, Fingar et al. 2002). The 
mTORC1 directly phosphorylates and activates S6K (Rui 2007). Thus the PI3K-
Akt can activate the mTORC1-S6K pathway.  
         Inhibition of hypothalamic mTOR by rapamycin attenuates leptin’s 
effects on food intake regulation (Cota, Proulx et al. 2006). Systemic deletion of 
S6K or selective inhibition of S6K in the ARC blocks leptin’s action in mice 
(Blouet, Ono et al. 2008; Cota, Matter et al. 2008). On the other hand, activation 
of S6K in the ARC enhances leptin sensitivity (Blouet, Ono et al. 2008). These 
data show that the mTOR-S6K pathway plays an important role in mediating 
leptin’s effect in the regulation of food intake.  
 
1.3.4.3 MAPK  pathway 
           SH2-containing protein tyrosine phosphatase 2 (SHP2) is a ubiquitously 
expressed cytoplasmic protein-tyrosine phosphatase that contains two NH2-
terminal SH2 domains. Leptin stimulates extracellular signal-regulated protein 
kinases 1 and 2 (ERK1/2) activation via SHP2 in cultured cells and the 
hypothalamus (Bjorbaek, Uotani et al. 1997; Takahashi, Okimura et al. 1997; 
Kim, Uotani et al. 2000; Bjorbaek, Buchholz et al. 2001; Zhang, Chapeau et al. 
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2004). Leptin stimulates phosphorylation of Ob-Rb on Tyr985 and SHP2 binds 
to it via its SH2 domain and acts as an upstream activator of the mitogen-
activated protein kinase (MAPK) pathway in leptin-treated cells (Carpenter, 
Farruggella et al. 1998; Li and Friedman 1999; Banks, Davis et al. 2000; 
Bjorbaek, Buchholz et al. 2001). Neuron-specific deletion of SHP2 results in 
leptin resistance and obesity (Zhang, Chapeau et al. 2004). Pharmacological 
inhibition of ERK1/2 in the hypothalamus also abrogates the ability of leptin to 
inhibit food intake and weight gain (Rahmouni, Sigmund et al. 2009). These 
studies showed that the SHP2/MAPK pathway is involved in mediating the role 
of leptin in energy balance. 
 
1.3.4.4 The AMPK/ACC pathway 
           An increase in AMP/ATP ratio will activate 5’-AMP-activated protein 
kinase (AMPK), which functions as an energy sensor in multiple cell types 
(Kahn, Alquier et al. 2005). AMPK phosphorylates and inactivates acetyl-CoA 
carboxylase (ACC), a key enzyme in fatty acid biosynthesis (Kahn, Alquier et al. 
2005). Leptin inhibits AMPK in multiple regions of the hypothalamus and leads 
to the stimulation of ACC (Gao, Kinzig et al. 2007). Inhibition of hypothalamic 
AMPK reduces food intake and weight gain. In contrast, constitutive activation 
of hypothalamic AMPK increases food intake (Andersson, Filipsson et al. 2004; 
Minokoshi, Alquier et al. 2004). Inhibition of ACC also blocks leptin’s effect in 
inhibiting food intake, suggesting that ACC is a downstream mediator of AMPK 
(Gao, Kinzig et al. 2007). These findings suggest that the hypothalamic 
AMPK/ACC pathway mediates leptin’s anorexigenic action. However, it is 
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unclear whether leptin directly or indirectly regulates this pathway in 
hypothalamic neurons.  
 
1.3.5 Leptin resistance 
           Leptin resistance refers to the reduced ability of leptin to suppress food 
intake and to promote energy expenditure. The mechanisms of leptin resistance 
remain largely unknown. There are several possible mechanisms proposed 
including defects in leptin transport to brain, low expression of leptin receptor on 
cell membrane, impairment of leptin receptor signaling etc.  
         Impaired leptin receptor signaling is one of the important reasons leading 
to leptin resistance. Suppressor of cytokine signaling 3 (SOCS3) provides a key 
negative feedback mechanism to prevent over activation of leptin signaling. 
Leptin stimulates the expression of SOCS3 via Tyr1138 in Ob-Rb and STAT3. 
SOCS3 binds to JAK2 and phospho-Tyr985 on Ob-Rb and inhibits JAK2 and 
Tyr985 activity (Bjorbaek, Elmquist et al. 1998; Bjorbaek, El-Haschimi et al. 
1999; Bjorbak, Lavery et al. 2000; Eyckerman, Broekaert et al. 2000). Deletion 
of SOCS3 in a neuron-specific manner enhances leptin sensitivity and attenuates 
DIO (Howard, Cave et al. 2004; Mori, Hanada et al. 2004). SOCS3 expression in 
the hypothalamus increased dramatically in leptin-resistant animals, suggesting 
the involvement of SOCS3 in leptin resistance (Bjorbaek, Elmquist et al. 1998; 
Peralta, Carrascosa et al. 2002; Enriori, Evans et al. 2007). 
            Another molecule of interest as a negative regulator of leptin receptor 
signaling is protein-tyrosine phosphatase 1B (PTP1B) which can 
dephosphorylate JAK2 and inhibit leptin signaling (Elchebly, Payette et al. 1999; 
Cheng, Uetani et al. 2002; Zabolotny, Bence-Hanulec et al. 2002). Systemic or 
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neuron-specific knock-out (KO) of PTP1B improves leptin sensitivity and 
decreases body weight in mice (Cheng, Uetani et al. 2002; Zabolotny, Bence-
Hanulec et al. 2002; Bence, Delibegovic et al. 2006). PTP1B expression in 
hypothalamus increases in leptin-resistant animals, suggesting that PTP1B is a 
key player in leptin resistance (Morrison, White et al. 2007; White, Whittington 
et al. 2009). 
            In addition, many other factors also contribute to the development of 
leptin resistance including impairment in leptin transport (Caro, Kolaczynski et al. 
1996; Schwartz, Peskind et al. 1996; El-Haschimi, Pierroz et al. 2000), defects in 
Ob-Rb trafficking to the cell surface (Rahmouni, Fath et al. 2008; Seo, Guo et al. 
2009) and ER stress (Hosoi, Sasaki et al. 2008; Ozcan, Ozcan et al. 2008). 
Therefore, leptin resistance is induced by multiple mechanisms.  
 
1.3.6 Functions of leptin  
1.3.6.1 Energy homeostasis 
 Leptin regulates appetite mainly by acting on the brain through binding to 
the Ob-Rb in the hypothalamus. Within the ARC, there are neurons expressing 
the peptides POMC and CART which reduce food intake, whereas the other 
neurons expressing NPY and AgRP which stimulate feeding behavior (Coll, 
Farooqi et al. 2007; Coll, Yeo et al. 2008).  Leptin can immediately activate these 
anorexigenic and orexigenic neural circuit to control food intake. In addition to 
such immediate effects, long-term leptin administration can alter the synaptic 
plasticity among hypothalamic neurons (Bouret, Draper et al. 2004; Pinto, 
Roseberry et al. 2004). For example, leptin has been shown to increase the 
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number of synapses on POMC neurons and decrease the number of synapses on 
NPY neurons (Pinto, Roseberry et al. 2004). Leptin also can increase energy 
expenditure. In mice, leptin activates BAT thermogenesis through increasing 
sympathetic nerve activity (Haynes, Morgan et al. 1997). Thus, leptin inhibits the 
food intake and increases the energy expenditure to regulate the energy 
homeostasis.  
 
1.3.6.2 Neuroendocrine function 
 Leptin level decreases rapidly and leads to the changes in a variety of 
neuroendocrine hormones upon fasting (Ahima, Prabakaran et al. 1996; Chan, 
Heist et al. 2003; Chan, Matarese et al. 2006). The changes include a reduction in 
reproductive hormone level which limits procreation, a decrease in thyroid 
hormone level that inhibits the metabolic rate, an increase in growth hormone 
level that is necessary to mobilize energy stores, and a reduction in insulin-like 
growth factor-1 (IGF-1) level that inhibits the growth-related processes (Ahima, 
Prabakaran et al. 1996; Chan, Heist et al. 2003; Chan, Williams et al. 2008).  
Interventional studies in human and mice showed that leptin administration can 
restore the changes in the hormones (Ahima, Prabakaran et al. 1996; Heiman, 
Ahima et al. 1997; Farooqi, Jebb et al. 1999; Farooqi, Matarese et al. 2002; Chan, 
Heist et al. 2003), suggesting that leptin regulates the levels of neuroendocrine 
hormones.  
 
1.3.6.3 Insulin resistance and obese syndromes 
            Lack of leptin causes various metabolic syndromes including insulin 
resistance. In the ob/ob mouse and human with congenital leptin deficiency, 
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leptin treatment decreases the glucose and insulin level and improves the levels 
of lipoprotein and triglycerides, but the underlying mechanisms are still not clear 
(Harris, Zhou et al. 1998; Farooqi, Matarese et al. 2002). 
 In addition, in lipoatrophy mouse models, hypoleptinemia leads to the 
metabolic abnormalities such as hyperglycemia, insulin resistance, and 
hyperlipidemia (Gavrilova, Marcus-Samuels et al. 2000). Transplantation of 
adipose tissue (Gavrilova, Marcus-Samuels et al. 2000; Kim, Gavrilova et al. 
2000) which produces leptin and treatment with exogenous leptin (Shimomura, 
Hammer et al. 1999) in lipoatrophic mice improve hyperglycemia, insulin 
resistance and other abnormalities in metabolism. All these data suggest that 
leptin is involved in the insulin resistance and metabolic syndromes. 
  
1.3.6.4 Bone metabolism 
  In 2000, Ducy and colleagues showed that ob/ob mice had a high bone 
mass phenotype (Ducy, Amling et al. 2000). However, later it was reported that 
leptin’s effect on murine bone varies in different skeletal regions (Cirmanova, 
Bayer et al. 2008). Ob/ob mice have lower bone mass than normal lean mice 
regarding the whole-body volume (Cirmanova, Bayer et al. 2008) .  
 Leptin affects bone metabolism through both central and peripheral 
actions. In mice, leptin regulates the sympathetic tone and the downstream 
formation of cortical bone (Mantzoros, Magkos et al. 2011). The sympathetic 
tone in ob/ob mice is decreased (Takeda, Elefteriou et al. 2002), and leptin  
increases it through the action on the VMH (Mantzoros, Magkos et al. 2011). In 
addition, the β1- and β2-adrenergic receptor KO mice which had lower 
sympathetic tone showed decreased bone mass and low leptin levels (Mantzoros, 
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Magkos et al. 2011). Leptin may also mediate cortical bone formation by 
regulating the expression of several hypothalamic neuropeptides that positively 
or negatively affect bone metabolism such as NPY and serotonin (Baldock, 
Allison et al. 2006; Yadav, Oury et al. 2009). It is unclear whether the knowledge 
obtained from rodent studies also applies to humans; therefore, the role of leptin 
in human bone metabolism needs further investigation.  
 
1.4 The classic protein secretory pathways 
          The contents of eukaryotic cells are organized into different membrane-
bound compartments such as ER and the Golgi apparatus. All eukaryotic cells 
continuously insert membrane vesicles into PM by exocytosis (Palade 1975). The 
exocytosis process contains a serial of events that take place in the different 
organelles composing the secretory pathway including ER, ER exit sites (ERES),  
ER-to-Golgi intermediate compartment (ERGIC), Golgi complex, and trans-
Golgi network (TGN) (Szul and Sztul). 
 Proteins are synthesized on the cytoplasmic surface of the rough ER 
(RER). Those to be secreted are translocated into the ER lumen where several 
kinds of modifications take place: the cleavage of signal peptide, the proper 
folding of the polypeptide, formation of disulfide bonds, and adding of glycans to 
the newly synthesized protein. Once the protein has been properly modified, it is 
packaged into vesicular carriers and delivered to the Golgi complex. Traffic from 
the ER to the Golgi complex is mediated by the coat protein II (COPII) coat 
complex (Lee, Miller et al. 2004), and retrograde traffic from the Golgi to the ER, 
as well as intra-Golgi transport, is controlled by the coat protein I (COPI) coat 
(Beck, Rawet et al. 2009). ERES are smooth projections of the ER which 
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generate COPII-coated vesicles and these vesicle carriers transport the cargo to 
the next compartment in the secretory pathway, the ERGIC. The ERGIC is a 
sorting compartments composed of vesiculo-tubular profiles that are found 
adjacent to ERES which gives rise to relatively large anterograde-destined 
transport intermediates to Golgi (Presley, Cole et al. 1997; Hirschberg, Presley et 
al. 1999). In addition, the ERGIC also sorts the proteins to be sent back to the ER 
(COPI vesicles) and retained the resident ERGIC proteins. 
         In the Golgi, further modifications occur: the glycan side chains are 
extended, and proteins synthesized as precursors are processed (Burgess and 
Kelly 1987). Finally, proteins are sorted in TGN, and then transported to their 
final destinations via cytoskeleton. At the target sites, the vesicles are tethered to 
the PM and fuse with it to release the cargo protein.  
 
1.4.1 RER transport 
           Secretory protein starts the journey to the outside of cells by being 
translocated into the lumen of the RER. The key factors for this process include: 
the signal peptide, signal-recognition particle (SRP), and the SRP receptor (SR). 
Newly synthesized secretory proteins are selectively targeted to the ER by the 
finely controlled function of the above three factors (Walter and Lingappa 1986). 
          Signal peptide is an N-terminal extension of the nascent polypeptide 
chain which is usually cleavable (Blobel and Dobberstein 1975; Walter and 
Johnson 1994). The number of amino acids composing signal peptides varies 
from 15 to more than 50 amino acid residues, but signal peptides have some 
features in common. There are three functional regions in signal peptides, 
hydrophobic central region (h-region), N-terminal region (n-region) and carboxy-
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terminal (c-terminal) region. The most crucial one is the h-region which is the 
hydrophobic central region of 6-15 amino acids. The h-region is important for 
protein targeting. The polar n-region and c-region flank the h-region and the c-
region contains a signal peptidase cleavage site (Martoglio and Dobberstein 
1998).  
           SRP of mammalian cells consists of six proteins, SRP9, SRP14, SRP19, 
SRP54, SRP68 and SRP72K, and 7SL RNA (Walter and Blobel 1980; Walter 
and Blobel 1982). As the nascent protein emerges from the ribosome, the SRP 
can recognize and bind to its hydrophobic signal peptide (Walter, Ibrahimi et al. 
1981). In mammalian cells, SR is a heterodimer consisting of the SRα (Gilmore, 
Walter et al. 1982) and the SRβ (Tajima, Lauffer et al. 1986). Both SRα and SRβ 
are guanosine triphosphatase (GTPase). SRα is a peripheral membrane protein 
and it is anchored to the ER through its association with the integral membrane 
protein SRβ. The GTPase activity of SRβ is required for the stable formation of 
the SR complex (Schwartz and Blobel 2003). 
           The process of entering the RER is characterized by a well understood 
sequence of events: first, the N-terminal signal sequence of the nascent 
polypeptide is recognized on the ribosome by SRP, and then the SRP-ribosome 
complex is targeted to the membrane via the SRP receptor. Next, the nascent 
chain is transferred from SRP to the protein conducting channel (Schwartz 2007). 
In mammalian cells, translocation to the ER lumen occurs simultaneously with 
protein synthesis, i.e. cotranslationally.  
           During the process of protein translocation to the lumen of the RER, the 
nascent polypeptide is folded to its correct three-dimensional conformation with 
help of chaperones. In addition, modifications such as signal peptide cleavage, 
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N-linked glycosylation, and disulfide bond formation are carried out by resident 
RER enzymes. Once the protein is properly folded and modified, it is ready to 
exit ER. 
            Exit from the RER can be affected by a variety of factors such as ATP 
availability and temperature. Both inhibitors of ATP production (Jamieson and 
Palade 1968; Tartakoff and Vassalli 1977; Tartakoff, Vassalli et al. 1978) and 
low temperature (10-15C) (Saraste and Kuismanen 1984; Saraste, Palade et al. 
1986; Tartakoff 1986) can block the protein exit from the RER. Protein assembly 
or conformation may be critical for their exit from the RER. Mutations on the 
secretory proteins can block the exit from the RER.  
 
1.4.2 ER-Golgi transport 
 The transport of proteins between the different cellular organelles is 
accomplished by vesicular transport carriers. Small membrane vesicles are 
created by the action of coat proteins that shape the membranes into membrane 
vesicles and at the same time select ‘cargo’ proteins to be included into these 
vesicles (Kirchhausen 2000; Bonifacino and Lippincott-Schwartz 2003). Traffic 
from the ER to the Golgi complex is mediated by COPII and retrograde traffic 
from the Golgi to the ER, as well as intra-Golgi transport, is controlled by the 
COPI. 
 
1.4.2.1 Antegrade COPII vesicles transport 
          Proteins transport from ER to Golgi is mediated by the COPII coat 
complex which begins at ERES. COPII is a set of highly conserved proteins that 
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is responsible for creating small membrane vesicles that originate from the ER 
(Barlowe, Orci et al. 1994; Lee, Miller et al. 2004). The formation and movement 
of COPII derived-vesicles is the first step in the cellular secretion pathway. The 
COPII coat machinery consists of five cytosolic proteins: Sar1, Sec23, Sec24, 
Sec13 and Sec31. In cells, Sec23 and Sec24 form the inner COPII coat in tight 
heterodimers; however, Sec13 and Sec31 form the outer COPII coat in stable 
heterotetramers of two subunits of each (Barlowe, Orci et al. 1994). Sar1 and 
these two types of stable complexes are sequentially recruited to the ER 
membrane and work together to create a complete COPII coated membrane 
vesicle. COPII proteins from the cytosol and cargo proteins on the membrane are 
recruited to ERES to exit ER (Bannykh, Rowe et al. 1996; Budnik and Stephens 
2009).            
         Sar1 is a small GTPase which has intrinsic GDP-to-GTP exchange 
catalyzed by the Sec12 guanine nucleotide exchange factors (GEF) (Barlowe and 
Schekman 1993; Sato and Nakano 2005). Sar1 is the first one to be recruited to 
the ER membrane, which initiates the process of vesicle formation. The Sec23-
Sec24 sub-complex arrives at ER membrane through direct interaction between 
Sar1 and Sec23 (Bi, Corpina et al. 2002). Sec24 is reported to be the primary 
subunit critical for binding of the COPII complex to membrane cargo proteins at 
the ER and concentrating them into the forming vesicle (Miller, Antonny et al. 
2002). Many cargo proteins have specific export-signal sequences in their 
cytoplasmic domains to mark them for COPII transport so that they can be 
selected into the membrane vesicles. The Sec13-Sec31 heterotetramer completes 
the process of membrane cargo sorting and vesicle fission. This outer layer of the 
coat collects pre-budding complexes and shapes the membrane to form a bud that 
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is enriched in cargo proteins. With the full set of COPII proteins assembled into a 
polymerized coat, the extruded membrane is separated from the donor ER 
membrane by fission to form an intact vesicle about 60–70 nm in size and  
carries cargo proteins to the ERGIC. 
 
1.4.2.2 Retrograde COPI vesicles transport 
 Retrograde traffic from the Golgi to the ER, as well as intra-Golgi 
transport, is controlled by the COPI coat complex. There are three locations 
where COPI vesicles may bud from: the ERGIC, the anterograde carriers moving 
to the Golgi, and the Golgi cisterna.  The COPI coat consists of seven subunits 
(coatomers): α, β, β’, γ, ε, δ, δ which form two subcomplexes: a trimeric complex 
composed of α, β’, ε, and a tetrameric complex composed of β, γ, δ, and δ 
(Eugster, Frigerio et al. 2000). The trimeric complex form the outer layer of the 
COPI coat and the tetrameric complex forms the inner core of the COPI coat 
(Lee and Goldberg ; Hoffman, Rahl et al. 2003). In addition, two isoforms of the 
γ (γ 1 and γ 2) and δ subunits (δ 1 and δ 2) have been identified (Blagitko, Schulz 
et al. 1999). The COPI vesicles containing different subunits isoform localize in 
different sites suggesting that the different types of COPI coats may be 
responsible for different transport routes and traffic different cargo between 
different compartments. 
          Generation of a COPI transport vesicle includes several steps: coat 
recruitment, uptake of cargo, budding, membrane separation (scission), and 
uncoating. The most important factor for the formation of COPI vesicles is the 
small Ras-like GTPase ADP-ribosylation factor 1 (Arf1). Arf1 cycles between a 
GDP-loaded inactive cytosolic state and an active, membrane bound, GTP-
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loaded state (Randazzo, Yang et al. 1993). GEFs are the molecular switch to 
activate Arf1 and Arf GTPase activating proteins (Arf GAPs) convert activated 
Arf1 into its inactive GDP form. 
           Upon Arf1 activation, coatomers are recruited to Golgi membranes 
(Donaldson, Kahn et al. 1991; Palmer, Helms et al. 1993). The complex is 
recruited to the Golgi membrane en bloc (Hara-Kuge, Kuge et al. 1994) and  
forms multiple interfaces with Arf1-GTP. Cargo proteins are directed into COPI 
vesicles by binding to the coat through the sorting motifs in their sequences. 
After inclusion of cargo proteins, the polymerization of coatomers and/or the 
activated Arf leads to the deformation of a flat donor membrane into a curved 
bud and the following separation from the donor membrane to complete the 
coating (Beck, Sun et al. 2008). These COPI vesicles may traffic back to the ER 
or may transport cargo to adjacent compartments, for example from trans- to 
medial-Golgi. 
 
1.4.3 Transport in Golgi complex 
            The Golgi apparatus is made up of three different parts namely cis-, 
medial-, and trans-Golgi. Secretory proteins are transported through these three 
compartments in a vectorial manner (Pfeffer and Rothman 1987). During the 
process of transport from medial- to trans-Golgi, carbohydrate modifications, 





1.4.4 Trans-Golgi Network 
         Secretory proteins are transported from trans-Golgi to TGN after being 
modified in the Golgi apparatus. TGN is the post-Golgi sorting compartment in 
which proteins with different signals are recognized and sorted into different 
secretory pathways such as regulated secretory pathway (RSP) and constitutive 
secretory pathway (CSP). 
          Protein secretion that can be regulated by a secretagogue is called 
regulated secretion. Most of the neurotransmitters, neuropeptides, and hormones 
are secreted by RSP (Burgess and Kelly 1987). Secretory proteins are 
concentrated inside secretory granules and stored in organelles in the cytosol. 
Upon stimulation, the secretory protein can be released from the condensed 
granules; therefore regulated secretion is protein synthesis independent. Another 
type of protein secretion is called constitutive secretion. Proteins secreted by this 
pathway are not concentrated in secretory granules for storage in the cytoplasm. 
They are constantly secreted and secretagogue stimulation is not required. It is 
the basic form of secretion and is driven by the secretory protein biosynthesis. 
           In TGN, different polypeptide hormones are sorted into the RSP by two 
proposed models: sorting-at-entry and sorting-by-retention. For sorting-at-entry 
mode, peptide hormone precursors and granins aggregate together in a pH- (6.0-
6.5) and cation-dependent manner. Constitutive secretory proteins are  excluded 
during this process of aggregation (Bauerfeind and Huttner 1993). After that, the 
aggregate binds to the TGN membrane via receptor proteins. The TGN 
membrane then buds to form the vesicle containing aggregated protein cargo. In 
sorting-by-retention model, regulated secretory proteins and some constitutive 
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secretory proteins enter the immature secretory vesicle together at the TGN. In 
the secretory vesicle maturation process, the regulated secretory proteins are 
retained in the maturing vesicle by binding to a retention receptor (Arvan and 
Castle 1998). 
 
1.4.5 Post-Golgi vesicle trafficking  
         The newly formed RSP and CSP vesicles are subjected to clathrin coating 
which leads to the maturation of the vesicles (Steiner, Michael et al. 1987; 
Teuchert, Schafer et al. 1999). Adaptor protein 1 (AP-1) and Golgi localized, γ-
ear-containing ADP-ribosylation factor binding protein (GGA) are the major 
adaptor proteins mediating clathrin coating on CSP and RSP vesicles (Doray, 
Ghosh et al. 2002; Kakhlon, Sakya et al. 2006).  
           After budding from the TGN, both RSP and CSP vesicles are transported 
along the microtubule-based transport system (Goldstein and Yang 2000; Rudolf, 
Salm et al. 2001). Different anchor and adaptor proteins are required for the 
vesicles to be associated with the microtubule. Microtubule motors, such as 
kinesin, are used for anterograde transport and cytoplasmic dynein are for the 
retrograde transport (Goldstein and Yang 2000) . 
           At the end of the microtubule network, both RSP and CSP vesicles are 
shifted to the actin cortex near the PM with the help of F-actin motor protein, 
Myosin V (Brown, Peacock-Villada et al. 2002). Myosin V carries both CSP and 
RSP vesicles through the F-actin-rich cortical region to the secretion sites 




1.4.6 Vesicles tethering and membrane fusion 
After being transported through the actin cortex, the vesicles are tethered 
to the PM. Some RSP vesicles do not tether to the PM and make up of a reserved 
pool for exocytosis. Among the RSP vesicles that are tethered to the PM, a 
subpopulation of this pool of vesicles namely the readily releasable pool, are 
immobilized and docked and primed at the PM and ready for exocytosis. RSP 
vesicle tethering and docking are facilitated by the small GTPase Rab proteins 
and their effectors. Rab3A and Rab27A are the major Rab proteins regulating the 
tethering of RSP vesicles and assembly/disassembly of a fusion complex 
between the RSP vesicles and the PM (Tsuboi and Fukuda 2006). There are 
several molecules shown to be the effectors of Rab3A and Rab27A including 
Rab3D, Rabphilin3A, Rab3-interacting molecule (Rim), and Noc2 for Rab3A, 
and Granuphilin-A for Rab27A. Tethering of CSP vesicle is mediated by exocyst 
which is an eight-subunit protein complex (Kee, Yoo et al. 1997).  
After tethering, RSP vesicles undergo docking, priming, and fusion to the 
PM with the help of soluble NSF attachment protein receptor (SNARE) proteins 
and calcium sensors such as Synaptotagmins (Syts). SNARE proteins are defined 
by the presence of a SNARE motif of about 60 residues, which is characterized 
as having a high potential for coiled-coil formation (Gerber and Sudhof 2002). 
Two classes of PM SNAREs (synaptosomal-associated protein-25 [SNAP-25] 
and syntaxins) interact with one class of vesicular SNARE (synaptobrevins, also 
called vesicle-associated membrane proteins [VAMP]) in exocytosis (Sollner, 
Whiteheart et al. 1993). Syts comprise a family of at least 16 proteins which are 
primarily expressed in neurons with different subcellular localizations. All Syts 
contain an N-terminal transmembrane region, a central linker sequence, and two 
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After tethering, the GTP-bound form of Rab3A on RSP vesicles binds to 
Rim1 on PM. Rim1 is released from Rab3A upon GTP hydrolysis, which 
activates Munc13. The activation of Munc13 initiates the interaction between 





sensor Syt binds the SNARE complex and triggers membrane 
fusion between vesicles and the PM (Park and Loh 2008). Thus, secretory 
proteins travel all the way from ER to Golgi, sorted at the TGN and transport 
along the post-Golgi trafficking route to the secretion site to be released. 
 
1.5 Role of calcium in protein secretion 
  Calcium plays an important role in neurotransmitter release and hormone 
secretion. Many polypeptide hormones, such as insulin and glucagon, are 
secreted from endocrine tissues using calcium as a key second messenger (Lang 
1999; Gerber and Sudhof 2002).  Calcium is required at multiple steps in the 
exocytotic process and the most established function of calcium in exocytosis is 
its triggering effect at membrane fusion step. In neurons, the neurotransmitter 
release is initiated by action potential. Arriving at the presynaptic terminal, action 
potential opens Ca
2+
 channels, and the calcium concentration increases locally 
which activates calcium sensor Syts. The Ca
2+
 binds to the two C2-domains of 
Syts and leads to the interaction of C2-domains with phospholipids and SNARE 
proteins and the subsequent membrane fusion (Sudhof 2012). In pancreatic β-
cells, glucose metabolizes to generate ATP and leads to the closure of ATP-
sensitive K
+





 channels are open (Fridlyand and Philipson 2011). Calcium binds 
to Syt 7 and leads to the subsequent membrane fusion of insulin granules and PM 
(Gustavsson, Lao et al. 2008).  
In endocrine glands, Ca
2+
 not only triggers membrane fusion, but also 
serves to mobilize the vesicles and accelerate their priming for fusion. Kinesin 
together with myosin Va moves the insulin granules along the microtubules to 
the PM. This process requires ATP and calcium but not a simple increasing in 
cytosolic Ca
2+
 (Varadi, Ainscow et al. 2002).  Calcium is critical in reshaping the 
cortical actin by stimulating gelsolin, which in turn affects the access of insulin 
granules to PM for membrane fusion (Tomas, Yermen et al. 2006). Calcium also 
plays important roles in regulating insulin secretion by binding to proteins 
involved in insulin secretion such as calcium dependent activator protein for 
secretion 1 (CAPS1), calmodulin and calmodulin-dependent protein kinase such 
as calcineurin (Renstrom, Ding et al. 1996). 
 
1.6 Regulation of leptin production and secretion 
        Leptin is mainly secreted from white adipocytes. Other tissues such as 
BAT and gastric mucosa also secrete leptin. Serum leptin level is tightly 
regulated by many factors. The stimulators of leptin release include: food intake 
(Thompson 1996), insulin, glucose, glucocorticoids, amino acids, fatty acids etc. 
There are also factors leading to decreased leptin level such as fasting, cold 
exposure, exercise, β-adrenergic activation. Leptin level is regulated by these 
factors at different levels including the ob gene transcription, leptin mRNA 




1.6.1 Regulation of leptin transcription 
          Leptin production is under transcriptional control by nutrition status and 
hormone level changes. It was reported that the leptin mRNA level is increased 
in obesity (Lonnqvist, Arner et al. 1995; Maffei, Halaas et al. 1995), and long-
term overfeeding status (Harris, Ramsay et al. 1996). On the contrary, long term 
starvation (Lee, Yang et al. 2007) and hormones related to starvation such as 
catecholamines (Fried, Ricci et al. 2000; Rayner and Trayhurn 2001) can 
decrease leptin mRNA level. 
          Insulin is one of the most studied hormones regulating leptin production. 
However, the effect of insulin on leptin transcription is still controversial. Insulin 
treatment for 48 h increased leptin transcription in 3T3-L1 cells (Moreno-Aliaga, 
Stanhope et al. 2001), whereas short term insulin treatment (1-2 h) on rat 
adipocytes increased leptin release with no effect on the mRNA level (Bradley 
and Cheatham 1999; Lee, Yang et al. 2007). Further study showed that the 
transcription inhibitor actinomycin D does not affect insulin-stimulated leptin 
release from isolated rat adipocytes (Bradley and Cheatham 1999), suggesting 
that acute insulin effect on leptin secretion may be posttranscriptional. 
         Other hormones and cytokines were also reported to regulate leptin 
transcription. Dexamethasone, a synthetic glucocorticoid, increased leptin 
mRNA level and leptin release from rat adipocytes after 2 h of incubation 
(Bradley and Cheatham 1999; Bradley, Kokkotou et al. 2000). Leptin expression 
was decreased by TNF-α after long time of treatment (Trujillo, Lee et al. 2006). 
Neuropeptides such as melanin-concentrating hormone (Bradley, Kokkotou et al. 
2000) and NPY (Kos, Harte et al. 2007) may also regulate leptin production at 
transcriptional level regulation, but further study is needed to confirm it. All 
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these data suggest that nutrition status leads to changes in hormonal and neural 
signals which regulate leptin production at least in part at the level of leptin 
transcription. 
 
1.6.2 Regulation of leptin translation 
           Starvation, insulin and adrenergic agonists were shown to affect leptin 
translation as well (Ricci, Lee et al. 2005; Lee, Yang et al. 2007). Biosynthetic 
labelling was used to investigate this in rat adipose. Starvation overnight 
decreased relative rate of leptin biosynthesis with little effect on mRNA levels. 
Insulin increased the rates of leptin synthesis without affecting leptin mRNA 
levels in vitro. The β adrenergic receptor (β-AR) agonists decreased leptin 
synthesis within hours at the posttranscriptional level. Incubation of rat adipose 
tissue with isoproterenol, a β -AR agonist, blocked the insulin- stimulated leptin 
biosynthesis without affecting leptin mRNA levels (Ricci, Lee et al. 2005). Thus, 
insulin and catecholamines counterregulate leptin biosynthesis. 
 
1.6.3 Regulation of leptin secretion 
1.6.3.1 Leptin-containing compartment 
           In 1994, when ob gene was first cloned, the group showed that the 
product of in vitro translation of ob gene would translocate into the microsomal 
lumen in the presence of microsomal membrane and can be protected from 
digestion of proteinase K (Zhang, Proenca et al. 1994). However, this is never 
clearly shown in the primary adipocytes.  
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         The subcellular localization of leptin remains inconclusive. It has been 
shown that the compartmentalization of intracellular leptin in adipocytes is a 
novel type of a secretory compartment that is different from both glucose 
transporter 4 (GLUT4)-containing vesicles and peptide-containing secretory 
granules present in endocrine cells (Roh, Thoidis et al. 2000). The authors 
separated the rat adipocytes into five crude subcellular fractions including: 1) 
first low-speed pellet (mitochondria, nuclei, and lysosomes), 2) PM), 3) HM 
(intermediate fraction enriched with endoplasmic reticulum, but also containing 
PM and LM markers), 4) LM, which contains Golgi apparatus, endosomes, TGN, 
and 5) cytosol. Leptin was found mainly in the HM and LM. Then they further 
fractionated the HM and LM in 10-50% equilibrium density sucrose gradient and 
10-30% continuous sucrose velocity gradient respectively and they found that 
leptin did not have the same distribution as GLUT4 and the marker proteins for 
the secretory granules, secretogranin II and chromogranin as well as synaptic 
vesicles marker synaptophysin. In 2001, the same group reported that leptin had 
the different subcellular localization from that of lipoprotein lipase, another 
important protein secreted from white adipocytes (Roh, Roduit et al. 2001).  
 Immunostaining methods were also used to study the leptin-containing 
compartment. Barr and colleagues showed that leptin colocalized with the ER 
(Barr, Malide et al. 1997). They did immunostaining on primary adipocytes and 
found that leptin colocalized well with the ER marker calnexin. Another group 
also showed ER localization of leptin (Xie, O'Reilly et al. 2008). The authors 
used 3T3-L1 adipocytes and binding immunoglobulin protein (BiP) as the ER 
marker and they found that leptin colocalized well with BiP. However, Roh and 
co-workers did not find the ER localization of leptin (Roh, Roduit et al. 2001). 
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They did immunostaining to show that leptin did not colocalize with the ER 
marker calreticulin. Electron microscopy study also contributed to the knowledge 
about the cellular localization of leptin-containing vesicles. Immunogold-labeling 
study showed that leptin-positive vesicles were near the nucleus and along the 
thin cytoplasmic rim around the lipid droplet as well as at the RER (Cammisotto, 
Bukowiecki et al. 2006). Taken together, it is still controversial on the ER 
location of leptin and further evidence is needed to elucidate this. 
            Regarding the Golgi localization of leptin, it is also inconclusive. TGN38, 
a marker of the TGN was used in the immunohistochemistry of rat WAT. It was 
shown that leptin localized in small spherical structures located near the nuclei of 
the adipocytes and co-localize with TGN38. Immunolabelling of leptin revealed 
that leptin-containing vesicles localized at smooth cisternae that could 
correspond to the Golgi apparatus (Cammisotto, Bukowiecki et al. 2006). 
However, another group claimed that leptin was never seen to be coloclized with 
TGN38 in rat adipocytes. Furthermore, it was shown that leptin displayed no 
colocalization with TGN marker syntaxin 6 in 3T3-L1 cells (Xie, O'Reilly et al. 
2008). Therefore, the identity and subcellular localization of leptin-containing 
structure need to be further studied. 
 
1.6.3.2 Regulated or constitutive  
       Insulin was reported as one of the most important stimulators of leptin 
secretion (Barr, Malide et al. 1997; Bradley and Cheatham 1999; Cammisotto, 
Gelinas et al. 2005). However, it remains unsettled whether insulin-stimulated 
leptin is through regulated secretory pathway. One of the most important features 
of regulated secretion is that the stimulated secretion is new protein synthesis 
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independent (Burgess and Kelly 1987). Some studies reported that insulin-
stimulated leptin secretion can be inhibited by the protein synthesis inhibitor 
CHX (Levy and Stevens 2001; Turban, Hainault et al. 2001; Cammisotto, 
Bukowiecki et al. 2006). Bradley and colleagues showed that CHX inhibited 
basal leptin secretion, but insulin could still stimulate a two fold increase in 
leptin secretion (Bradley and Cheatham 1999). Another group also reported that 
in the presence of CHX for 1 h, insulin still stimulated leptin secretion 
significantly (Lee and Fried 2006). On the other hand, it was shown that CHX 
could not inhibit insulin-stimulated leptin secretion (Roh, Thoidis et al. 2000), 
suggesting the possibility of a regulated leptin secretion induced by insulin. 
Further study is needed to elucidate whether insulin-stimulated leptin secretion is 
regulated secretion or not. 
 
1.6.4 Insulin sigaling regulates leptin production and secretion 
1.6.4.1 Insulin-PI3K-Akt pathway 
Insulin binds to its receptors on PM to activate the downstream signaling 
pathways. IR is composed of two extracellular α-subunits and two 
transmembrane β-subunits. Insulin binds to the α-subunits which induces a 
conformational change leading to the consequent activation of intrinsic tyrosine 
kinase of the β-subunits. Activated IR phosphorylates insulin receptor substrate 1 
(IRS1), IRS2 and Shc proteins (Pessin and Saltiel 2000). Phosphorylation of 
IRSs provides binding sites for specific proteins containing Src homology 2 
(SH2) domains such as PI3K (Burgering and Coffer 1995). 
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There are three classes of PI3Ks namely class I, class II and class III. The 
classes 1 PI3Ks consist of a regulatory p85 and a catalytic p110 subunit (Escobedo, 
Navankasattusas et al. 1991; Hiles, Otsu et al. 1992). SH2 domain of the regulatory 
p85 subunit interacts with phosphotyrosine residues on IRS1, which leads to the 
recruitment of PI3K to the PM. Activation of PI3K results in the addition of 
phosphate on the D3 position of phosphatidylinositol and production of phosphatidyl-
inositol 3-phosphate and other 3-phosphorylated inositides (PI3P).  
Akt protein is encoded by Akt gene. It is a serine/threonine kinase with the 
pleckstrin homology domain (PH) in its NH2 terminal region. The catalytic domain of 
Akt is closely related to protein kinase C (PKC) and protein kinase A (PKA) family 
members (Staal 1987), therefore Akt is also named as protein kinase B (PKB). 
Mammalian genomes contain three Akt genes, Akt1, Akt2, and Akt3 that encode 
three isoforms of Akt kinase respectively. In adipose tissue, Akt2 is the predominant 
isoform. 
The PH domain of Akt kinases has an affinity for PI3P and the binding of 
PI3P triggers Akt translocation to the PM (Bellacosa, Chan et al. 1998). Insulin 
induced activation of Akt resulted from its phosphorylation at two residues, 
Threonine308 (Thr308) and Serine473 (Ser473) by 3-phosphoinositide-dependent 
protein kinase-1 (PDK1) and mTOR-RICTOR complex (mTORC2) respectively 
(Alessi, Andjelkovic et al. 1996; Alessi, James et al. 1997; Sarbassov, Guertin et al. 
2005). Phosphorylation at Thr308 is necessary for Akt activation and Ser473 
phosphorylation is required for its maximal activity (Downward 1998).  
Insulin-PI3K-Akt pathway plays critical roles in adipocytes such as regulation 
of glucose uptake, protein synthesis, glycogen synthesis, gluconeogenesis, cell 
survival and lipid metabolism (Brazil, Yang et al. 2004). Akt is involved in glucose 
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metabolism by regulating GLUT4 trafficking. Knock-down of Akt2 in adipocytes 
reduced insulin-stimulated GLUT4 translocation (Jiang, Zhou et al. 2003). KO of 
Akt2 in mouse adipocytes leaded to insulin-resistance induced by impaired glucose 
uptake and GLUT4 trafficking (Cho, Mu et al. 2001). 
The PI3K-Akt pathway is also required for protein synthesis at the 
translational level. Eukaryotic initiation factor 4E (eIF4E) and its binding protein 4E-
BP1 are essential translational regulatory factors.  The eIF4E is inactive in a complex 
with 4E-BP1 in resting status and is released by the phosphorylation of 4E-BP1. Upon 
insulin stimulation, mTOR is phosphorylated by Akt (Scott, Brunn et al. 1998), which 
in turn phosphorylates 4E-BP1 and activate gene translation.  
 
1.6.4.2 Insulin signaling pathways involved in leptin secretion 
          Many studies have shown the stimulatory effect of insulin on leptin 
production and secretion, but the downstream signaling pathways are not well 
defined. PI3K, mTOR and MAPK pathway were shown to be involved in 
insulin-stimulated leptin biosynthesis and secretion in rat adipocytes (Bradley 
and Cheatham 1999; Cong, Chen et al. 2007; Lee, Yang et al. 2007). On the 
contrary, another group reported that insulin regulated leptin secretion in a PI3K 
pathway independent manner in 3T3-L1 cells (Zeigerer, Rodeheffer et al. 2008). 
Therefore, whether PI3K is involved in insulin-stimulated leptin secretion 
remains inconclusive. 
 The downstream targets of PI3K responsible for leptin production and 
secretion were also investigated. Akt is one of them. Expression of constitutively 
active Akt induced an increase in leptin protein levels without affecting leptin 
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mRNA levels (Barthel, Kohn et al. 1997).  Phosphodiesterase 3B (PDE3B) is 
another possible molecule downstream of PI3K. PDE3B mediates the anti-
lipolytic action of insulin through reduction of cAMP in adipocytes (Manganiello, 
Degerman et al. 1992). Inhibition of PDE3B blocked the insulin-stimulated leptin 
secretion (Cong, Chen et al. 2007).  It was also reported that mTORC1 could be a 
critical downstream mediator of the insulin stimulation of leptin translation. 
Increasing mTORC1 activity increases leptin translation (Chakrabarti, Anno et al. 
2008). More evidence is needed to prove the functions of these molecules in 
mediating insulin-stimulated leptin secretion. 
 
1.6.5 Role of calcium in leptin secretion 
           The role of calcium as an indispensable factor for neurotransmitter release 
and hormone secretion has been widely documented and accepted. Many 
polypeptide hormones, such as insulin and glucagon, are secreted from endocrine 
tissues using intracellular calcium as a key second messenger (Lang 1999; 
Gerber and Sudhof 2002). Furthermore, an abnormal cellular calcium 
homeostasis has been shown to be involved in obesity and type 2 diabetes 
(Jeremy, Gill et al. 1995; Levy 1999). Accumulating evidence suggests that 
leptin secretion is dependent on calcium. It was reported that both intra- and 
extracellular calcium was important for insulin-stimulated leptin secretion in rat 
adipocytes although no clear underlying mechanism was shown (Levy, Gyarmati 
et al. 2000). In another study, the essential role of extracellular calcium for 
insulin-stimulated leptin secretion is suggested to be attributed to its permissive 
role in glucose uptake with no apparent direct role in leptin exocytosis --- a 
40 
 
mechanism that challenges the established role of calcium in polypeptide 
hormone release (Cammisotto and Bukowiecki 2004). The precise role of 
calcium in leptin secretion and the underlying mechanisms remain to be 
elucidated.  
 
1.7 Aims and strategies 
1.7.1 Aims 
      The aims of the present study are to elucidate: first, the secretory pathway 
that basal and insulin-stimulated leptin secretion goes through; second, the 
downstream signaling pathways involved in insulin-stimulated leptin secretion; 
third, the potential role of calcium in leptin secretion. 
 
1.7.2 Strategies 
           Mouse primary adipocytes and 3T3-L1 cells will be used in in vitro 
study. A combination of various in vitro techniques, including molecular cloning, 
immunocytochemistry, confocal and total internal reflection fluorescence (TIRF) 
microscopy and biochemical analysis will be used. The molecular control of 
leptin secretion was studied several aspects:  
1) The characteristics of leptin-containing compartment were examined 
by biochemical and bioimaging methods;  
2) The short term (< 2 h) effect of insulin on leptin secretion from 
adipocytes was investigated;  
3) The potential role of calcium in leptin secretion was tested. Intra-and 
extracellular calcium chelators and ionophores were used. 
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4) Whether insulin-stimulated leptin secretion is through regulated 
secretory pathway was studied. The protein synthesis inhibitor CHX and ER-
Golgi trafficking blocker BFA were used.  
5) The signalling pathways involved in insulin-stimulated leptin secretion 
were studied. Pharmacological inhibitors to different kinases were used. For in 
vivo studies, DIO mice were used to analyse the plasma leptin level at different 
conditions. 









Chapter 2, Materials and Methods 
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2.1 Animal welfare 
Eight to twelve weeks of male C57BL/6 mice were obtained from 
biological resource center of Agency for Science, Technology and Research 
(A*STAR) and were housed in individual cages at 24 °C with a 12:12-h light-
dark cycle. The mice received standard chow and water ad libitum.  
The Syt7 KO mice were generated on C57BL/6 background as described 
previously (Maximov, Lao et al. 2008). Syt7 heterozygous mice were used for 
breeding to generate homozygous mutant and littermate controls.  
To have DIO mice, C57BL/6 male mice were divided into two groups at 
the age of 7 weeks, with one group receiving high fat diet (HFD) (Research Diet 
D12492) and the other receiving chow diet (Research Diet D12450B) and for 16 
weeks. All experiments involving animals were reviewed and approved by the 
Institutional Animal Care and Use Committee of A*STAR. 
 
2.2 Chemicals 
         Antibodies against calnexin, KDEL, early endosome antigen 1 (EEA1) 
were from Abcam; synataxin 6 antibody was from BD; golgin97 antibody was 
from Invitrogen; antibodies against caveolin1, phospho-Akt (Ser473), Akt, 
phosphor-MAPK and MAPK were from Cell Signaling Technology. Insulin, 
wortmannin, akt1/2 inhibitor akti and ionomycin were purchased from 
Calbiochem. Ethylene glycol-bis (beta-aminoethyl ether)-N,N,N',N'-tetraacetic 
acid acetoxymethyl ester (EGTA-AM), 1,2-bis-(2-amino-phenoxy)ethane- 
N,N,N',N'-tetraacetic acid (BAPTA), Fura-2 and collagenase type IV were 
obtained from Invitrogen. Proteinase inhibitor cocktail was from Roche, ECM 
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gel, ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid 
(EGTA), 1,2-bis-(2-amino-phenoxy) ethane-N,N,N',N'-tetraacetic acid 
acetoxymethyl ester (BAPTA-AM) and other chemicals were all obtained from 
Sigma-Aldrich.  
 
2.3 3T3-L1 cells culture 
        3T3-L1 fibroblast were obtained from the American Type Culture 
Collection (ATCC, Bethesda, MD) and were cultured in DMEM supplemented 
with 25 mM glucose, 10% calf serum at 37 °C with 5% CO2. For differentiation, 
3T3-L1 cells were grown to confluence and the culture medium was changed to 
DMEM supplemented with 10% fetal bovine serum to culture for 2 days. At this 
point, referred to as day 0, 3T3-L1 cells were differentiated by inducer medium 
containing 1 μg/ml insulin, 500 μM methyl-isobutyl-xanthine (IBMX), and 1 μM 
dexamethasone (Dex) for 2 days. The cell culture medium was changed to insulin 
medium containing 1 μg/ml insulin in DMEM supplemented with 10% fetal 
bovine serum on day 2 and cultured for another 2 days. On day 4, the culture 
medium was changed to DMEM with 10% fetal bovine serum and cultured to 
day 8-10 with medium changed every 2 days.  
 
2.4 Construction of pLenti-Leptin-Venus and pLenti-Venus plasmids 
         The Leptin-Venus construct was obtained by inserting the cDNA of 
Venus between the signal sequence and the cDNA of leptin by the following 
steps. First, full length leptin sequence was amplified with XhoI and NotI cites at 
each end by polymerase chain reaction (PCR). Second, the amplified leptin 
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sequence with XhoI and NotI sites was put into the pEGFP-N1 vector replacing 
the EGFP sequence and this plasmid was named as pLeptin. Third, in pLeptin, 
the sequence of agt gcc between the signal sequence and leptin sequence was 
mutated to ggt acc (KpnI cutting cite) and a linker region having KpnI and AgeI 
cite at each end was inserted after the signal sequence by cutting the pLeptin with 
KpnI.  After the insertion of this linker, the old KpnI cite was destroyed and this 
plasmid was referred as pLeptin-linker. Fourth, the Venus sequence was 
amplified by PCR with KpnI and AgeI at each end and inserted into the pLeptin-
linker by cutting pLeptin-linker with KpnI and AgeI. Thus, pLeptin-Venus was 
constructed. The pVenus was made by inserting the Venus sequence amplified 
by PCR with XhoI and NotI cites into the pEGFP-N1 vector. The Leptin-Venus 
and Venus sequence in pLeptin-Venus and pVenus was cut out with NheI and 
HpaI and inserted to pLenti-hiko lentiviral construct to make the pLenti-Leptin-
Venus and pLenti-Venus constructs.   
 
Table 1 Primers for construction of pLeptin-Venus and pVenus 
Primer name Primer Sequence 
Full length leptin forward 5'-  gc ctc gag atg tgc tgg aga ccc ctg tgt c   -3' 
Full length leptin reverse 5'- gc gcggccgc cta gca ttc agg gct aac atc caac-3' 
Mutagenesis forward 5'- gtc tta tgt tca agc ggt acc tat cca gaa agt gc -3' 
Mutagenesis reverse 5'- gc act ttc tgg ata ggt acc gct tga aca taa gac -3' 
Linker forward 5'-ga ggt acc gga acc ggt gtac-3' 
Linker reverse 5'- acc ggt tcc ggt acc tc gtac-3' 
Venus forward (pLeptin-Venus) 5'-  cg ggt acc ctg gtg agc aag ggc gag   -3'  
Venus reverse (pLeptin-Venus) 5'-  cg acc ggt ctt gta cag ctc gtc cat gc   -3'  
Venus forward (pVenus) 5'-  gc ctc gag ctg gtg agc aag ggc gag   -3' 
Venus forward (pVenus) 5'- gc gcggccgc ctt gta cag ctc gtc cat gc   -3' 
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2.5 Lentivirus production and viral infection 
          The pLenti-Leptin-Venus or pLenti-Venus was co-transfected with 
lentivirus packaging vectors into HEK 293T cells by calcium phosphate method. 
Briefly, HEK 293T cells were seeded in 10 cm culture dishes pre-coated with 
poly-L-lysine and culture to 80-90% confluence. The cell culture medium was 
changed to fresh medium 1 h before transfection. To prepare the calcium 
phosphate-DNA co-precipitate for one 10 cm culture dish of cells, the plasmids 
mix (pMD2G 5 µg, pMDLg/pRRE 10 µg, pRSV-Rev 5 µg, pLenti-Venus or 
pLenti-Leptin-Venus 20 µg) was added to 100 µl of 2.5 M CaCl2  and  ddH2O up 
to 500 µl in a 1.5 ml microcentrifuge tube. Falcon tubes (50 ml) containing 500 
µl of two times HEPES-buffered saline (2X HeBS) were prepared. The CaCl2-
DNA mix solution was slowly dripped into 2X HeBS solution and mixed by 
bubbling with a 1 ml mechanical-seriological pipette in HeBS solution during the 
addition.  The total transfection solution volume should now be 1000 µl. Let the 
50 ml falcon tube stand at room temperature (RT) for 30 min to allow for 
precipitation. The mix was added to HEK 293T cells drop by drop and the cell 
culture medium was swirled to mix well. 
Cell culture medium was changed after 16 h of culture and the culture 
medium containing virus particles was harvested after another 24 h and 48 h. The 
medium was centrifuged at 1200rpm for 10 min to remove cell debris. The 
supernatant was used to infect 3T3-L1 fibroblast. Fresh 3T3-L1 culture medium 
and virus containing medium were mixed in a 1:1 ratio and added to wt 3T3-L1 
cells. Polybrene (8 µg/ml) was added to enhance the efficiency of viral infection. 
Cell culture medium was changed after 16 h and the cells showed fluorescence 
about 48 h after virus infection. Cells were not selected as almost 100% of the 
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cells were infected (by observation under fluorescent microscope). 3T3-L1 cells 
stably expressing Leptin-Venus fusion protein was designated as 3T3-LV cells 
and the cells stably expressing Venus was designated as 3T3-V cells as control. 
 
2.6 Primary white adipocytes isolation and adipokines measurement 
           Primary white adipocytes were isolated from mouse epididymal fat pads 
as reported with a slight modification (Cammisotto and Bukowiecki 2004). 
Briefly, mouse epididymal fat pads were collected from five mice and pooled 
together  in a 50 ml Falcon tube containing 15 ml of ice-cold Krebs-Ringer 
Hepes (KRH) buffer of the following composition (mM): 130 NaCl, 4.7 KCl, 1.2 
KH2PO4, 1.2 MgSO4, 25 glucose, 20 HEPES, and 1% fatty acid-free bovine 
serum albumin (BSA) (1% KRH), pH 7.4, with CaCl2 (2.5 mM). The fat tissue 
was minced well with scissors in tissue culture hood and washed once with fresh 
1% KRH buffer. After washing, the adipose tissue was incubated in fresh 1% 
KRH buffer containing 20 mg/ml collagenase Type IV  at 37°C for 30-60 min 
(depending on the amount of tissue) with a shaking frequency of 150 cycles/min.  
At the end of the digestion, the adipose tissue was filtered through a mesh 
and washed. All the following procedure was done in tissue culture hood and in 
RT to keep the secretion activity of adipocytes. The digested adipose tissue was 
filtered through a 200 µm nylon filter (Biomed Diagnostics) by washing with 1% 
KRH buffer. The white layer floating on the top of the solution contains white 
adipocytes. The adipocytes were taken out and washed with the 1% KRH buffer 
and centrifuged at 100g for 1 min to remove the stromal vascular cells. The cells 
were washed and centrifuged for 3 times to get pure adipocytes. Adipocytes in 
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warm 1% KRH buffer were mixed well and aliquot to 2 ml eppendorf tubes (500 
µl of KRH buffer containing adipocytes) and equilibrate at 37°C for 30 min 
(shaking frequency of 50 cycles /min).  
After equilibration, the adipocytes in eppendorf tubes were washed with 4% 
KRH buffer 3 times (by centrifugation at 100g  for1 min at RT, and KRH buffer 
at the bottom was removed by gel loading pippete tips with minimum 
disturbance to the cells) and 200 µl of  4% KRH buffer was added to each 
eppendorf tube. The adipocytes were pretreated with agents to be tested for 30 
min and then incubated with or without insulin for 2 h.  
For studies performed in the absence of extracellular calcium, cells were 
washed 3 times with a calcium-free 4% KRH containing 5 mM BAPTA or 
EGTA and then adipocytes were incubated in the calcium free KRH buffer for 30 
min. After pretreatment in calcium free KRH buffer, the cells were incubated in 
the presence or absence of insulin for 2 h. At the end of incubations, the media 
were collected and frozen at -80°C for adipokines measurement. Leptin and 
adiponectin concentration was determined by ELISA using kits purchased from 
Millipore.  
 
2.7 Subcellular fractionation 
         Subcellular fractionation was performed as described (Joost and 
Schurmann 2001) with modifications. Primary white adipocytes were isolated 
from 20 male mice and pooled together. Isolated primary adipocytes were 
washed once with 20 ml Tris-EDTA-sucrose (TES) buffer (20 mM Tris-HCl, 1 
mM Ethylenediaminetetraacetic acid [EDTA], 8.7% sucrose; pH 7.4) and 
suspended in TES buffer. Adipocytes were then homogenized in the pre-cooled 
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(4 °C) Potter-Elvehjem grinder with 20 hand strokes and then centrifuged at 
12,000 rpm for 1 min at RT, and for 15 min at 4 °C. Solidified fat at the top was 
removed and discarded. The supernatant was centrifuged at 20,000 rpm for 30 
min at 4 °C. The pellet contains the high-density microsomes (HDM) and was 
suspended to be centrifuged again at 20,000 rpm. The supernatant after the 
20,000 rpm centrifugation was further centrifuged for 75 min at 200,000g (4 °C) 
to pellet the low-density microsomes (LDM). The pellet was suspended, and 
centrifuge again at 200,000g. The pellet of the first centrifugation (12,000 rpm) is 
suspended in TES buffer (2 ml Potter; 20 strokes), loaded on the sucrose cushion 
(38.5%), and centrifuged for 60 min at 100,000g (4 °C) in a swing-out rotor. The 
resulting pellet contains nuclei and mitochondria. PM was collected from the top 
of the sucrose cushion, suspended in TES buffer, and pelleted by centrifugation 
at 31,000g for 60 min. All the pellets were suspended and homogenized in 0.4-1 
ml TES. 
        For differentiated 3T3-LV adipocytes, cells (10XT75 flasks) was washed 
twice with TES (4 °C), and scraped off the carrier with a rubber policeman. Cells 
were homogenized in TES buffer in Potter-Elvehjem grinder with 15 hand 
strokes. Homogenized cells were centrifuged at 8000g for 15 min. All subsequent 
centrifugations are identical to the steps performed in the fat cell fractionation. 
 
2.8 Trypsin protection assay 
          Trypsin protection assay was performed as described previously (Tanaka, 
Nozaki et al. 2007). Briefly, differentiated 3T3-LV adipocytes were rinsed 3 
times with ice-cold phosphate buffered saline (PBS) and scraped with a rubber 
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policeman, harvested in ice-cold PBS, and collected by centrifugation at 800g at 
4 °C for 5 min. The cells were suspended in 500 µl of an ice-cold buffer (2 mM 
MgCl2, 2 mM CaCl2, 50 mM NaCl, 250 mM sucrose, and 50 mM Tris/HCl, pH 
7.4) and homogenized with 20 strokes using 25 gauge needles. Cell lysate was 
collected by centrifugation at 1000g at 4 °C for 10 min. The samples were treated 
for 2 h at 4 °C with or without 0.5 mg/mL Trypsin or Triton X-100 (1% w/v). 
For primary adipocytes, the adipocytes were isolated and washed with ice-cold 
PBS. Then the cells were homogenized and treated same as the 3T3-LV 
adipocytes. Samples were separated on sodium dodecyl sulfate polyacrylamide 




         3T3-LV cells were cultured and differentiated to day 7-9 and re-plated 
on poly-L-lysine-coated coverslips and cultured overnight. The cells were 
washed with PBS for 3 times, fixed in PBS containing 4% paraformaldehyde for 
10 min. Next, the cells were permeabilized in PBS containing 0.2% saponin for 5 
min, and blocked in  blocking buffer (3% BSA, 3% goat serum in PBS) for 1 h at 
RT. The cells were then probed by antibodies indicated and fluorescence-
conjugated secondary antibodies (555) (Invitrogen). The coverslips were 




2.10 TIRF microscope imaging 
           TIRF microscope imaging was carried out at 30 ºC using an inverted 
microscope system (Nikon) equipped with a 100×1.45 NA TIRF objective. 3T3-
LV and 3T3-V cells were cultured and differentiated to day 7-9. The cells were 
re-plated on poly-L-lysine-coated coverslips and cultured overnight. The 
coverslips with cells were mounted in a home-made chamber and incubated in 4% 
KRH buffer. The cells were imaged under light microscope and then switch to 
TIRF microscope. Venus was excited by a 488 nm laser and the emission 
wavelength was collected at 520 nm. The laser beam was incident on the 
coverslip (refractive index ~1.52) at 68-70˚ from the normal. The penetration 
depth of the evanescent field is calculated to be ~100 nm.  
 
2.11 RNA extraction and Real-time PCR 
          Primary white adipocytes were isolated and treated with or without 
insulin for 2 h. Total RNA was extracted from primary adipocyte using RNeasy 
Mini columns (Qiagen) following the manufacturer’s instruction. Total RNA was 
treated with DNase I (Roche) and complimentary DNA was prepared using the 
RevertAid kit (Fermentas) following the manufacturer’s instruction. Quantitative 
Real-time PCR was performed using Syber green assays for mouse leptin, 
GLUT4, insulin receptor (IR) on Step One Plus Real-Time PCR System (Applied 
Biosystems). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as 






Table 2 Primers for Real-time PCR 
Primer name Primer Sequence 
Leptin forward 5'-caa gca gtg cct atc cag a 
Leptin reverse 5'-aag ccc agg aat gaa gtc ca 
GAPDH forward 5'caa ggt cat cca tga caa ctt tg 
GAPDH reverse 5'ggc cat cca cag tct tct gg 
GLUT4 forward 5'gtg act gga aca ctg gtc cta 
GLUT4 reverse 5' cca gcc acg ttg cat tgt ag 
IR forward 5' ccg aag att tcc gag acc tca g 
IR reverse 5' gga tac ggg acc agt cga tag tg 
 
 
2.12 Western blot 
          After treatment and incubation, adipocytes were washed with BSA free 
KRH buffer with or without calcium for 3 times and lysed in whole cell lysis 
buffer containing (mM): 280 KCl, 1 EDTA, 20 HEPES, 0.1 Na3VO3, 10% 
glycerol, 0.5% NP40, 20 NaF, 1 dithiothreitol (DTT), 1 phenylmethylsulfonyl 
fluoride (PMSF), protease inhibitor cocktail (Roche). Protein was resolved in 
SDS-PAGE, transferred to polyvinylidene fluoride (PVDF) or nitrocellulose 
membranes, and probed with antibodies using protocols provided by the 
suppliers. Visualization of protein bands was achieved using a standard 
enhanced-chemiluminescent reaction. 
 
2.13 Calcium imaging  
            Freshly isolated mouse adipocytes were loaded with 3 μM Fura-2 
(Invitrogen) for 40 min in 4% KRH buffer. Then the cells were rinsed 3 times 
with fresh 4% KRH buffer and stick to the coverslip using ECM gel. The 
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coverslip was placed in the perifusion chamber on the stage of an inverted 
microscope (Nikon Eclipse TE2000-U) and continuously perifused with 4% 
KRH buffer at 37 ºC in ambient atmosphere. The Fura-2 signal was excited at 
488nm using 175 watt xenon arc lamp. Emitted signal was collected with 
535DF35 band pass optical filter (Omega Optical) using a CCD camera 
(Coolsnap HQ2, Photometrics). The adipocytes were perifused with 4% KRH 
buffer for 10 min and stimulated with ionomycin (10 µM) or insulin (1 µg/ml) 
for 40 min. Images were collected at 10 s intervals and fluorescence signals from 
individual cells were measured as a function of time using Metafluor software 
(Molecular devices). The intracellular calcium concentration ([Ca2+]i) was 
reported as the ratio of Fura-2 fluorescence intensity resulting from the two 
excitation wavelengths at 340 nm and 380 nm, respectively (F340/F380). 
 
2.14 Body composition measurement 
 The body composition of age-matched HFD and control mice was 
measured at age of 23-24 weeks using an EchoMRI-100 (Echo Medical Systems) 
essentially as previously described (Gustavsson, Lao et al. 2008). Briefly, 
unanaesthetized mice were weighed first before they were put in a mouse holder 
and inserted in MRI analyzer. Readings of body fat mass and body lean mass 
were given within 1 min. 
 
2.15 Plasma hormone measurement 
 Blood samples were collected from tail vein of mice for leptin 
concentration measurements. Plasma samples were prepared by centrifugation of 
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blood samples at 8,000 g for 5 min at 4 °C. Mouse Leptin ELISA kit (Millipore) 
was used for plasma leptin measurements. 
 
2.16 Data analysis and statistics 
          All leptin concentration data were normalized to the respective basal 
leptin concentration of adipocytes and presented as means±SEM. Statistical 
comparisons were performed by ANOVA, posttest (Turkey) following ANOVA 









Chapter 3, Results   
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 In this chapter, leptin secretory pathway and the potential role of calcium 
were first investigated. Next, the signaling pathways involved in insulin-
stimulated leptin secretion were further explored in vivo and in vitro. At last, the 
mechanism underlying the involvement of calcium in leptin was explored. 
 
3.1 Characteristics of leptin-containing compartment 
To study the secretory pathway that leptin goes through, the intracellular 
localization of leptin was first investigated as it is not completely known. 3T3-L1 
cell line stably expressing Leptin-Venus fusion protein was made. Both the stable 
3T3-L1 cell line and primary adipocytes were used in the following study. 
 
3.1.1 3T3-LV and 3T3-V cells  
            3T3-L1 cell line is a well-established cell culture system that is used to 
study adipogenesis, fatty acid metabolism and insulin-regulated vesicles 
trafficking. 3T3-L1 fibroblasts differentiated with the standard 
isobutylmethylxanthine/dexamethasone/insulin (IBMX/Dex/Ins) protocol 
differentiate into mature adipocytes, but only express small amounts of leptin,  
which limited their application in studying leptin secretion (Norman, Isidori et al. 
2003). As the endogenous ob gene expression level in 3T3-L1 cell line is barely 
detectable, a 3T3-L1 cell line that stably expresses Leptin-Venus fusion protein 
was engineered. Venus is one of the variants of yellow fluorescent protein (YFP) 
which contains a novel mutation, F46L. This mutation greatly accelerates the 
oxidation of the chromophore at 37 °C, the rate-limiting step of maturation. Thus 





has been successfully fused with NPY and was monitored under microscope 
(Nagai, Ibata et al. 2002).  Therefore, Venus instead of GFP was chosen in the 
present study.  
           First, the cDNA sequence of Venus was inserted at the C-terminus of 
leptin cDNA, however, the Leptin-Venus fusion protein was truncated and there 
was free Venus in the cells when detected by western blot (data not shown). 
Therefore, the cDNA sequence of Venus was inserted at the N-terminus after the 
signal peptide sequence of leptin (Fig.1A). 3T3-L1-Leptin-Venus (3T3-LV) and 
3T3-L1-Venus only (3T3-V) stable cell lines were created via lentiviral infection. 
Cell lysates from HEK 293T cells, wt 3T3-L1, 3T3-V and 3T3-LV cells were 
immunoblotted using leptin and GFP antibodies. Leptin-Venus fusion protein 
displayed an expected molecular mass (~43 kDa). There was no apparent 
truncation or free Venus protein in 3T3-LV cells (Fig. 1B).  
           To evaluate whether over expression of Venus or Leptin-Venus affects 
the secretory function of 3T3-L1 cells, leptin secretion of these two stable cell 
lines were examined. The stable cells were differentiated to mature adipocytes as 
described in Materials and Methods. At day 8, 3T3-V and 3T3-LV adipocytes 
were serum starved for 2 h and followed by 1 µg/ml insulin treatment for 2 h. 
The culture medium was collected and subjected to leptin concentration 
measurement by ELISA. As shown in Fig. 1C, these cells secreted leptin and 
insulin increased leptin secretion significantly in both cell lines, suggesting that 









Figure 1 3T3-L1 cells stably expressing Leptin-Venus or Venus 
(A) Venus sequence was inserted to the N terminus of leptin next to the signal 
sequence.  
(B) Cell lysates of HEK 293T cells transfected with pLeptin-Venus (LV) or 
pVenus (V), 3T3-L1 (WT), stable 3T3-V (V), 3T3-LV (LV) cells were analyzed 
with antibodies against GFP or leptin. 
(C) 3T3-V and 3T3-LV cells were differentiated into mature adipocytes and 
treated with (black bar) or without (white bar) insulin for 2 h. The culture 
medium was collected for leptin concentration measurement by ELISA. Bars and 




3.1.2 Leptin is stored in membrane-bound vesicles 
When ob gene was first cloned, the group showed that the in vitro 
translation product of ob gene would translocate into the microsomal lumen in 
the presence of microsomal membrane and can be protected from the digestion of 
Proteinase K (Zhang, Proenca et al. 1994). However, this is never clearly shown 
in intact adipocytes. Therefore, whether leptin is stored into membrane-bound 
compartment was studied.  
 The 3T3-V and 3T3-LV cells were differentiated into mature adipocytes 
and re-plated on poly-L-lysine coated-coverslips before live microscope imaging. 
The localization of Venus alone in 3T3-V cells was homogenous throughout the 
cell including the nucleus region as visualized under Epi-fluorescence. On the 
contrary, Leptin-Venus fusion protein appeared to be localized only in cytosol in 
3T3-LV cells. Furthermore, Leptin-Venus fusion protein was seen to be close to 
the PM under TIRF microscope and appeared to be punctate distribution, 
suggesting that leptin might be stored in small vesicles beneath PM. The free 
Venus protein in the 3T3-V cells did not display such a distribution pattern (Fig. 
2A).  
 To confirm the punctate pattern of Leptin-Venus as secretory vesicles, 
trypsin protection assay was performed whereby in both primary and 3T3-LV 
adipocytes, cell lysates were incubated in combinations of trypsin and Triton-
X100. The cell lysates were subjected to western blot after incubations. Leptin 
was detectable in cell lysates from 3T3-LV and primary adipocytes treated with 
trypsin alone as compared to actin and GLUT4 which are cytosolic and 
transmembrane proteins respectively. Leptin was however undetectable when 
incubated in the presence of both trypsin and TritonX-100 (Fig. 2B), suggesting 
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that leptin is protected from trypsin digestion by the membrane-bound of vesicles. 
Taken together, leptin was shown to be stored in membrane-bound vesicles and 






Figure 2 Leptin in membrane-bound vesicles 
(A) Expression of free Venus and Leptin-Venus in 3T3-L1 adipocytes under Epi-
fluorescent and TIRF microscope. The scale bar is 5 µm. 
(B) Cell lysates of 3T3-LV and primary adipocytes were incubated with 
combinations of trypsin and Triton X-100 at 4 °C as indicated, followed by 




3.1.3 Leptin-containing vesicles localized predominantly in ER and PM  
       ER and Golgi apparatus compose of classic secretory pathway. The 
localization of leptin in these subcellular organelles is still inconclusive. Leptin 
was earlier found to be localized to RER, Golgi apparatus, and in numerous small 
vesicles along the PM of isolated rat white adipocytes (Cammisotto et al., 2006). 
However, another group reported that leptin was not localized in Gogli apparatus 
(Xie, O'Reilly et al. 2008). To determine the subcellular localization of leptin-
containing compartment in mouse adipocytes, subcellular fractionation assay was 
performed in 3T3-LV cells and primary mouse white adipocytes. Furthermore, 
immunocytochemistry and confocal imaging was also applied in 3T3-LV cells. 
 First, subcellular fractionation was performed on both 3T3-LV and 
primary adipocytes. The cell lysates were fractionated into HDM, LDM and PM 
prior to western blotting (3T3-LV) or ELISA (primary adipocytes) analysis. In 
3T3-LV adipocytes, HDM was enriched in ER marker KDEL and calnexin and 
early endosome marker EEA1 (Fig. 3A). The Golgi marker Golgin97 and 
glucose transporter GLUT4 mainly appeared in LDM. The plasma membrane 
integrated protein Caveolin1, which is involved in vesicular trafficking (Alvarez, 
Fujita et al. 1999; Karlsson, Thorn et al. 2002), was enriched in HDM and PM. 
Leptin was subsequently found predominantly in HDM, with a small portion of 
leptin in PM, but no trace of leptin in LDM (Fig. 3A).  
In primary adipocytes, as the concentration of leptin in each subcellular 
fraction is too low to be detected by western blot, ELISA was used to determine 
the concentrations of leptin in these fractions. The concentrations of leptin in 
each fraction were normalized to that in HDM accordingly. As shown in Fig. 3B, 
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leptin was in high level in HDM and PM fractions when compared to LDM, 
which was consistent with the results in 3T3-LV adipocytes.  
 To further study the organelle localization of leptin, 3T3-LV adipocytes 
were fixed and immunostained against different organelle markers (Fig. 3C). 
Leptin colocalized with ER marker KDEL but not with calnexin. Leptin also did 
not show colocalization with EEA1, suggesting that leptin might not be secreted 
via endosome/lysosome pathway. The colocalization of leptin with TGN marker 
syntaxin 6 and Golgi marker Golgin97 was not detected here. Leptin appeared to 
be localized at PM under confocal microscope, but there was no significant 
colocalization between Caveolin1 and leptin-containing vesicles. Thus, the 
imaging study further strengthened the subcellular fractionation results.  
Taken together, these data strongly suggest that leptin is stored in the 
lumen of ER and membrane-bound vesicles beneath the PM of adipocytes. The 
ER partion of leptin may not be mature leptin-containing vesicles as leptin may 
need further modification in the following steps of trafficking. The leptin-
containing vesicles beneath PM may contain mature leptin; therefore whether 










Figure 3 Subcellular localization of leptin in 3T3-LV adipocytes 
(A) HDM, LDM and PM fractions were extracted from cell homogenates of 3T3-
LV adipocytes, followed by western blotting with indicated antibodies.  
(B) HDM, LDM and PM fractions were extracted from cell homogenates of 
primary adipocytes, followed by leptin ELISA. Bars and vertical lines indicate 
means±SE.  
(C) 3T3-LV adipocytes were fixed, permeablized, and probed with antibodies 




3.2 Insulin increases leptin secretion at post-transcriptional level 
       Insulin was reported as one of the most important stimulators of leptin 
secretion (Barr, Malide et al. 1997; Bradley and Cheatham 1999; Cammisotto, 
Gelinas et al. 2005), but it is still not clear whether insulin regulates the 
exocytosis process of leptin. Therefore, the effect of insulin on leptin secretion in 
the first 2 hours was examined. Primary adipocytes were isolated and incubated 
with or without insulin for 15, 30, 60 and 120 minutes after which the incubation 
medium was collected for leptin concentration measurement. Leptin 
concentrations at each time point were normalized to the basal leptin secretion 
concentration at 15 min.  
Insulin steadily increased leptin secretion in the first 2 hours of 
stimulation with an increase of about 20-30% at each respective time point (basal 
vs. insulin at 15min: 1.00±0.03 fold vs. 1.34±0.07 fold; 30 min: 2.28±0.09 fold 
vs. 2.80±0.09 fold; 60 min: 3.83±0.16 fold vs. 4.72±0.12 fold; 120 min: 
6.24±0.18 fold vs. 8.57± 0.19 fold; n=12, p<0.01 at each time point) (Fig. 4A). 
The increased leptin secretion by insulin stimulation at 15 and 30 min suggests 
that the leptin-containing vesicles trafficking processes (for example: ER-Golgi 
transport, post-Golgi transport, or membrane fusion) might be upregulated by 
insulin as well, since the time is too short for new protein synthesis.  Another 
possibility is that there is a preformed pool of leptin that is ready for insulin 
stimulation.  
         To further characterize insulin-stimulated leptin secretion, the effect of 
insulin on secreted leptin, intracellular leptin content and total leptin in 2 h time 
was next examined. Primary adipocytes were isolated and incubated with or 
without insulin for 2 h. The incubation medium and whole cell lysate was 
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collected for leptin concentration measurement. The amount of leptin in each 
group was normalized to the total (secreted+intracellular leptin) basal leptin 
amount. As shown in Fig. 4B, total leptin increased by about 10% after 2 h of 
insulin stimulation (basal vs. insulin: 1.00±0.02 fold vs. 1.11±0.02 fold, n=8, 
p<0.05), and secreted leptin increased also by about 10% of total leptin (basal vs. 
insulin: 0.29±0.02 fold vs. 0.40±0.03 fold, n=8, p<0.05). However, intracellular 
leptin content remained the same when compared to the untreated cells (basal vs. 
insulin: 0.71±0.02 fold vs. 0.70±0.01 fold, n=8, N.S.), suggesting that adipocytes 
might secret the newly produced leptin as they synthesize them when stimulated 
by insulin.  
To be noted, first, adipocytes secreted about 30% of its cellular leptin 
content in 2 h under basal condition and increase to about 40% upon insulin 
stimulation, suggesting a high basal secretion ratio and turnover rate of leptin. 
Second, adipocytes maintain the cellular level of leptin when treated with insulin 
in time scale of hours, suggesting that nascent leptin synthesis is accounted for 
increased leptin secretion. Combining together, it suggests that the acute 
exocytosis of leptin in response to insulin treatment is minimal, and the pre-
existing pool is largely released in a constitutive fashion.  
          As insulin was shown to increase ob mRNA level (Saladin, De Vos et al. 
1995), the next was to determine whether the effect of insulin on leptin secretion 
within 2 h is through transcriptional control or not. Primary adipocytes were 
incubated with or without insulin for 2 h and the total RNA was thereafter 
extracted, reverse transcribed and subjected to real-time PCR to determine the 
relative levels of ob transcripts. GAPDH was used as an internal control and 
GLUT4 and insulin receptor (IR) were used as negative controls. To make sure 
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that insulin was working well, the incubation medium was also collected and 
subjected to leptin concentration measurement.  
The leptin secretion test showed that insulin stimulated leptin secretion 
normally (data not shown). The real-time PCR results showed that a 2 hour 
insulin exposure did not affect leptin mRNA level (basal vs. insulin: 1.00±0.07 
fold vs. 0.89±0.03 fold, n=12, N.S.) (Fig. 4C) nor the GLUT4 (basal vs. insulin: 
1.00±0.08 fold vs. 0.90±0.06 fold, n=12, N.S.) (Fig. 4D) and IR mRNA levels 
(1.00±0.08 fold vs. 0.98±0.05 fold, n=12, N.S.) (Fig.4E). Thus, insulin promotes 
leptin secretion in the first 2 h without significantly affecting the ob gene 
transcription. Taken increased leptin secretion upon stimulation together, it 
implies that insulin treatment may promote leptin translation. Further 
investigation would be required to clarify whether it is via translation initiation, 







Figure 4 Insulin effect on leptin secretion, leptin content and mRNA level 
 (A) Primary adipocytes were treated with (black square) or without (white 
square) 1 µg/ml insulin for 15, 30, 60 and 120 min. The incubation media were 
collected and subjected to leptin ELISA. n=12, ** p<0.01 
(B) Primary adipocytes were treated with (black square) or without (white square) 
1 µg/ml insulin for 120 min. The incubation media and whole cell lysate was 
collected and subjected to leptin ELISA. Bars and vertical lines indicate 
means±SE. n=8, * p<0.05 
(C, D, E) Primary adipocytes were treated with or without 1 µg/ml insulin for 2 h 
and total RNA was extracted and subject to real-time PCR to determine the 





3.3 Potential role of calcium in leptin secretion 
Calcium plays an important role in neurotransmitter release and hormone 
secretion. Many polypeptide hormones, such as insulin and glucagon are secreted 
from endocrine tissues through regulated secretion and calcium is the key second 
messenger (Lang 1999; Gerber and Sudhof 2002). However, the precise role of 
calcium in leptin secretion is not completely understood. Here, it was shown that 
there is ER and PM pool of leptin-containing vesicles and insulin increased leptin 
secretion as early as 15-30 min, which suggests that insulin-stimulated leptin 
secretion might be classic regulated secretion. Therefore, whether insulin- 
stimulated leptin secretion is regulated secretion and mediated by calcium influx 
was investigated.  
 
3.3.1 Leptin secretion depends on both extra-and intracellular calcium  
Leptin secretion stimulated by insulin has been shown to be calcium 
dependent (Levy, Gyarmati et al. 2000; Cammisotto and Bukowiecki 2004). Here, 
whether intra- or extracellular calcium is essential for the release of leptin was 
further determined by removing either one of them. Extra- and intracellular 
calcium chelators and ionophore were used. 
To determine the importance of extracellular calcium in leptin secretion, 
equal amount of isolated mouse white adipocytes were pre-incubated in 4% KRH 
buffer containing either 2.5 mM calcium or 0 calcium plus 5 mM calcium 
chelator for 30 min before insulin (1 µg/ml) was added to stimulate leptin 
secretion. After 2 h incubation, incubation medium was collected and leptin 
concentration was determined by ELISA. Leptin concentrations in each group 
were normalized to the basal leptin secretion group accordingly. Slow calcium 
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chelator EGTA (5 mM) and fast calcium chelator BAPTA (5 mM) were used in 
the calcium free 4% KRH buffer respectively.  
Insulin increased leptin secretion by an average of 1.48±0.09 fold (p<0.01, 
n=11) (Fig. 5A and 5B). However, when extracellular calcium was removed and 
chelated by 5mM of EGTA or BAPTA, both basal (1.00±0.00 fold for basal, 
0.81±0.05 fold for EGTA, p<0.01, n=5; 1.00±0.03 fold for basal and 0.64±0.05 
fold for BAPTA, p<0.01, n=6) and insulin-stimulated leptin secretion 
significantly decreased (1.63±0.09 fold for insulin and 0.93±0.07 fold for 
EGTA+insulin, p<0.01, n=5; 1.36±0.13 fold for insulin and 0.76±0.082 fold for 
BAPTA+insulin, p<0.01, n=6) (Fig. 5A and 5B).  
To investigate the role of intracellular calcium in leptin secretion, 
intracellular calcium chelators EGTA-AM and BAPTA-AM were used. 
Modification of carboxylic acids with AM ester groups results in an uncharged 
molecule that can permeate cell membranes. Once inside the cell, the lipophilic 
blocking groups are cleaved by nonspecific esterases, resulting in a charged form 
that leaks out of cells far more slowly than its parent compound. Frequently, 
hydrolysis of the esterified groups is essential for binding of the target ion. 
Isolated white adipocytes were pre-incubated in the presence or absence 
of intracellular calcium chelator EGTA-AM or BAPTA-AM for 30 min. To 
effectively remove the free intracellular calcium, 500 µM of EGTA-AM was 
used. At this concentration, EGTA-AM significantly lowered basal (1.00±0.03 
fold for basal and 0.41±0.11 fold for EGTA-AM, p<0.01, n=6) and insulin-
stimulated leptin secretion (1.58±0.04 fold for insulin and 0.42±0.07 fold for 
[EGTA-AM]+insulin, p<0.01, n=6) (Fig. 5C). As the calcium affinity of 
BAPTA-AM is higher than that of EGTA-AM, 50 µM BAPTA-AM was 
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sufficient to significantly decrease basal (1.00±0.04 fold for basal and 0.65±0.15 
fold for BAPTA-AM, n=11, p<0.05) and insulin-stimulated leptin secretion from 
isolated white adipocytes (1.29±0.060 fold for insulin and 0.72±0.21 fold for 
[BAPTA-AM] + insulin, p<0.05, n=11) (Fig. 5D). Interestingly, the basal leptin 
secretion was only partially reduced, however, the insulin-stimulated leptin 
secretion was almost abolished when extracellular or intracellular calcium was 
removed, suggesting that both intra- and extracellular calcium is involved in 
basal leptin secretion, but is indispensable for insulin-stimulated leptin secretion. 
It was earlier reported that absence of extracellular calcium decreased 
insulin-stimulated leptin secretion by affecting glucose uptake (Cammisotto and 
Bukowiecki 2004). To examine this, experiments were carried out in 1% KRH 
buffer containing either glucose (glucose media) or pyruvate (pyruvate media); 
the latter effectively bypasses the effect of calcium on glucose uptake.   
Primary adipocytes were pretreated with 500 µM EGTA-AM for 30 min 
in glucose media and stimulated with insulin (1 µg/ml) for 2 h. Both basal and 
insulin-stimulated leptin secretion were inhibited by EGTA-AM (1.00±0.02 fold 
for basal and 0.36±0.02 fold for EGTA-AM, n=11, p<0.05; 1.36±0.03 fold for 
insulin, 0.42±0.02 fold for insulin+[EGTA-AM], n=11, p<0.05). When 
extracellular calcium was removed and 10 mM EGTA was applied in glucose 
media, both basal (1.00±0.02 fold for 2.5 mM calcium and 0.51±0.03 fold for 0 
calcium+EGTA, n=11, p<0.05) and insulin-stimulated leptin secretion decreased 
(1.36±0.03 fold for 2.5 mM calcium and 0.56±0.03 fold for 0 calcium+EGTA, 
n=11, p<0.05) (Fig. 5E). 
           EGTA and EGTA-AM in pyruvate media had the same effect as in 
glucose media (Fig. 5F). Insulin increased leptin secretion in pyruvate media 
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containing 2.5 mM calcium (1.00±0.06 fold for basal; 1.25±0.07 fold for insulin, 
n=10, p<0.05). Pretreatment of adipocytes with 500 µM EGTA-AM in pyruvate 
media containing 2.5 mM calcium decreased both basal and insulin-stimulated 
leptin secretion (1.00±0.06 fold for basal, 0.42±0.02 fold for EGTA-AM, n= 9, 
p<0.05; 1.25±0.07 fold for insulin; 0.46±0.017 fold for insulin+[EGTA-AM], 
n=8, p<0.05). When primary adipocytes were incubated in pyruvate media 
containing 0 calcium and 10 mM EGTA, basal (1±0.06 fold for 2.5 mM calcium, 
0.64±0.09 fold for 0 calcium+EGTA, n=8, p<0.05) and insulin-stimulated leptin 
secretion (1.25±0.066 fold in 2.5 mM calcium, 0.69±0.047 fold in 0 
calcium+EGTA, n=10, p<0.05) was inhibited compared to the secretion in 
pyruvate media containing 2.5mM calcium. Thus, both extra- and intracellular 
calcium is important for basal and insulin-stimulated secretion, and this effect is 
















Figure 5 Effect of extra-and intracellular calcium chelators on leptin 
secretion  
Primary adipocytes were incubated with (grey bar) or without (white bar) insulin 
(1 µg/ml) in KRH buffer containing calcium (2.5 mM) or calcium (0) plus 5mM 
EGTA (A) or BAPTA (B).  
Adipocytes were pretreated with 500 µM EGTA-AM (C) or 50 µM BAPTA-AM 
(D) for 30 min followed by insulin (1 µg/ml) treatment for 2 h. Bars and vertical 
lines indicate mean fold change of leptin secretion±SE. **p< 0.01. 
Primary adipocytes were incubated in glucose (E) or pyruvate (F) medium 
containing calcium (2.5 mM) or 0 calcium plus 10mM EGTA, and treated with 
or without 500 µM EGTA-AM for 30 min and followed by treatment with or 
without insulin as indicated in the figure. Bars and vertical lines indicate mean 
fold change of leptin secretion±SE. *p< 0.05 compared to basal leptin level in 
2.5mM Ca
2+
 KRH buffer. # p<0.05 compared to insulin-stimulated leptin level in 
2.5mM Ca
2+







3.3.2 Calcium influx alone is not sufficient for leptin secretion 
Increase in intracellular calcium concentration acts as a trigger for 
neurotransmitter release and the release of hormones such as insulin and 
glucagon. However, it remains unclear whether insulin-stimulated leptin 
secretion is mediated by calcium influx and whether an increase in intracellular 
calcium concentration alone could trigger leptin release from white adipocytes. 
To study this, calcium imaging method was used on primary adipocytes to detect 
the change of intracellular calcium concentration upon insulin stimulation.  
Primary adipocytes were loaded with the intracellular free calcium 
indicator Fura-2 for 40 min and washed with fresh KRH buffer. Then the 
adipocytes were exposed to either insulin or ionomycin in the presence of 
extracellular calcium, and the changes in intracellular free calcium were tracked 
real-timely. Representative traces were shown in Fig. 6A. The arrow in Fig. 6A 
showed the time when ionomycin or insulin was added to the incubation buffer. 
Insulin (1 µg/ml) did not induce calcium influx in primary adipocytes when 
compared to ionomycin (10 µM) which induced a rapid and sustained rise in 
intracellular calcium concentration (peak amplitude induced by ionomycin: 
0.103±0.012, n=8, by insulin: 0.003±0.001, n=6, p<0.01) (Fig. 6B). These data 
suggest that insulin-stimulated leptin secretin might not be mediated by calcium 
influx as insulin could not induce calcium rise in adipocytes. 
Next, whether calcium influx alone is sufficient to induce leptin secretion 
was examined. Intracellular calcium concentration was raised by applying 
ionomycin (10 µM). Ionomycin by itself had no significant effect on leptin 
secretion from primary adipocytes (1.00±0.02 fold for basal and 0.99±0.06 fold 
for ionomycin, n=11, N.S.). In addition, insulin-stimulated leptin secretion was 
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also not altered by ionomycin (1.48±0.09 fold for insulin and 1.42±0.15 fold for 
ionomycin+insulin, n=11, N.S.) (Fig. 6C). These data thus suggest that increase 
in intracellular calcium concentration alone is insufficient to trigger leptin 
secretion; though removing calcium from extra- or intracellular spaces 
significantly impairs leptin release. Hence, the role of calcium in mediating leptin 
release must involve other indirect pathways. 
Insulin-stimulated leptin secretion is not mediated by calcium influx, 
which suggests that leptin release upon insulin stimulation might not be the 
classic regulated secretion. Actually, there is conflicting reports regarding the 
secretory pathway that insulin-stimulated leptin secretion goes through. 
Therefore, whether insulin-stimulated leptin secretion is via regulated secretory 









Figure 6 Effect of calcium influx on leptin secretion 
(A) Representative intracellular calcium response trace following 1 µg/m insulin 
(dotted line) and 10 µM ionomycin (solid line) treatment in primary adipocytes. 
Arrow indicates the addition of ionomycin or insulin. 
(B) The peak amplitude induced by ionomycin (white square) and insulin (black 
square) in calcium imaging experiments.  
(C) Adipocytes were pretreated with 10µM ionomycin for 30 min and followed 














3.4 Insulin increases leptin secretion by promoting constitutive leptin 
secretion  
In addition to above collected findings showing high basal and mild 
stimulated secretion of leptin, direct measurement of exocytosis ready pre-
existing pool was used to elucidate the leptin secretion routes. One of the most 
important features of regulated secretion is that the protein to be secreted is 
packaged into dense core granules and stored in cytosol, therefore the stimulated 
secretion is new protein synthesis independent (Burgess and Kelly 1987). CHX is 
a commonly used protein synthesis inhibitor (Wilkie and Lee 1965). To 
determine whether translational control of leptin accounts for its insulin-
stimulated release, primary adipocytes were pre-incubated with the CHX prior to 
insulin stimulation. BFA, an ER to Golgi trafficking blocker was also used to 
evaluate whether insulin-stimulated leptin secretion is through regulated 
exocytosis. 
 Since basal leptin secretion is relative high as shown above, the minimum 
CHX pre-incubation time it takes to efficiently block basal leptin secretion was 
determined. Primary adipocytes were incubated with or without CHX (100 µg/ml) 
for 2, 4, and 6 h. After incubation, the incubation media and whole cell lysate 
were collected and leptin concentrations were determined by ELISA. Leptin 
amount in each group were normalized to the average of the intracellular leptin 
amount at the beginning of incubation. 
CHX significantly inhibited basal leptin secretion at 4 h and 6 h, but not 
at 2 h (2 h: 0.41± 0.06 fold for DMSO and 0.33±0.03 fold for CHX, n=9, N.S.; 4 
h: 0.55±0.10 fold for DMSO and 0.30±0.04 fold for CHX, n=9, p<0.05; 6 h: 
0.68±0.15 fold for DMSO and 0.28±0.03 for CHX, n=9, p<0.05) (Fig. 7A). 
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When adipocytes constitutively secreted leptin, the intracellular leptin amount 
decreased gradually, and there was about 60% of leptin left inside cells after 6 h 
of secretion (Fig. 7B). CHX treatment also significantly decreased the 
intracellular leptin amount at 2, 4, and 6 h of time (2 h: 0.78± 0.02 fold for 
DMSO and 0.66±0.01 fold for CHX, n=9, p<0.05.; 4 h: 0.70±0.02 fold for 
DMSO and 0.59±0.01 fold for CHX, n=9, p<0.05; 6 h: 0.64±0.02 fold for DMSO 
and 0.51±0.01 for CHX, n=9, p<0.05) (Fig. 7B). There was about 50% of leptin 
remaining inside adipocytes after 6 h of CHX treatment. To be noted, at the time 
point of 2 h, the intracellular leptin amount in CHX treated cells had already 
decreased significantly compared to control cells, but the leptin secretion at 2 h 
was not affected by CHX, suggesting that adipocytes may adjust leptin secretion 
according to the intracellular leptin content. There may be a threshold of 
intracellular leptin amount beyond which adipocytes will continuously secret 
leptin, otherwise, adipocytes will stop leptin secretion. 
Next, equal amount of primary adipocytes were divided into four groups 
and pretreated with or without CHX (100 µg/ml) for 4 h and then the incubation 
media were changed before treatment with or without insulin (1 µg/ml) and/or 
CHX for another 2 h. The incubation media and whole cell lysate were collected 
and subjected to leptin ELISA. The total leptin amount was calculated based on 
secreted and intracellular leptin concentrations. The leptin amounts in each group 
were normalized to the average of the total basal leptin amounts. 
Insulin promoted leptin secretion (0.31±0.02 fold for basal and 0.49±0.03 
fold for insulin, n=7, p<0.05) (Fig. 7D). Basal leptin secretion was almost 
undetectable after 4 h of pretreatment with CHX (0.31±0.02 fold for basal and 
0.06±0.00 fold for CHX, n=7, p<0.01) (Fig. 7D).  Furthermore, insulin failed to 
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stimulate leptin secretion in the presence of CHX (0.06±0.00 fold compared to 
0.07±0.00 fold, n=7, N.S) (Fig. 7D). Here, the intracellular leptin content 
remained unchanged after insulin treatment which is consistent with the previous 
result (0.69±0.02 fold for basal and 0.62±0.02 fold for insulin, n=7, N.S.) (Fig. 
7E). CHX treatment decreased the intracellular leptin level (0.69±0.02 fold for 
basal and 0.47±0.03 fold for CHX, n=7, p<0.01), and insulin did not have 
additional effect on intracellular leptin level in the presence of CHX (0.47±0.03 
fold for CHX and 0.44±0.03 fold for CHX+insulin, n=7, N.S.) (Fig. 7E). There 
was still significant amount of leptin remaining in adipocytes treated with CHX 
(about 50%); so the reason that insulin fail to stimulate leptin secretion after 
CHX treatment is not due to the depletion of intracellular leptin pool. These data 
demonstrated that protein synthesis inhibition directly abolished both basal and 
insulin stimulated secretion, suggesting that insulin-stimulated leptin secretion is 
protein synthesis dependent. 
To further confirm that the effect of CHX is specific to insulin-stimulated 
leptin secretion, the incubation media and whole cell lysates in above 
experiments were also subjected to adiponectin ELISA. Basal adiponectin 
secretion was not inhibited by CHX at 2 h (1.00±0.07 fold for DMSO and 
1.11±0.25, n=7, N.S.), but was significantly inhibited at 4 h and 6 h (4 h: 
1.54±0.11 fold for DMSO and 1.08±0.12 fold for CHX, n=7, p<0.05; 6 h: 
1.77±0.22 for DMSO and 1.14±0.17 fold for CHX, n=7, p<0.05) (Fig. 7G). 
Insulin increased adiponectin secretion after 2 h of incubation (1.02±0.03 fold for 
basal and 1.21±0.04 fold for insulin, n=7, p<0.01). After 4 h of CHX 
pretreatment, insulin still stimulated adiponectin secretion (0.64±0.03 fold for 
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CHX and 0.88±0.06 fold, n=7, p<0.01) (Fig. 7H), suggesting that the inhibition 
of insulin-stimulated leptin secretion by CHX was specific.   
 To further evaluate whether insulin-stimulated leptin secretion depends on 
vesicle trafficking in the early secretory pathway, the effect of BFA, an ER to Golgi 
trafficking blocker, on leptin secretion was investigated. Primary adipocytes were pre-
incubated with 5 µg/ml BFA for 30 min and followed by 1 µg/ml insulin stimulation 
for 2 h.  BFA significantly inhibited basal leptin secretion (1.00±0.03 fold compared 
to 0.50±0.02 fold, n=6, p<0.05), suggesting that leptin transports via ER-Golgi route 
(Fig. 7I). Furthermore, BFA significantly blocked insulin-stimulated leptin secretion, 
(0.50±0.02 fold compared to 0.53±0.01 fold, n=6, N.S) suggesting that ER-Golgi 
trafficking is essential for insulin-stimulated leptin secretion and the leptin pool at PM 
is not immediately ready for insulin stimulation (Fig. 7I). Taken together, these data 



















Figure 7 Effect of CHX and BFA on leptin secretion 
(A, B, C) Primary adipocytes were treated with (black square) or without (white 
square) 100 µg/ml CHX for 2, 4, and 6 h. The incubation medium (A) and the 
whole cell lysate (B) were collected and subject to leptin ELISA. (C) The total 
leptin was calculated based on secreted and intracellular leptin.  
(D, E, F) Primary adipocytes were pre-treated with or without CHX (100 µg/ml) 
for 4 h, and then the incubation buffer was changed and followed by treatment 
for 2 h as indicated in the figures. The incubation medium (D) and whole cell 
lysate (E) were collected and subject to leptin ELISA. (F) The total leptin was 
calculated based on secreted and intracellular leptin level 
(G) Primary adipocytes were treated with (black square) or without (white square) 
100 µg/ml CHX for 2, 4, and 6 h. The incubation medium (G) was collected and 
subjected to adiponectin ELISA.  
(H) Primary adipocytes were pre-treated with or without CHX (100 µg/ml) for 4 
h, and then the incubation buffer was changed and followed by treatment for 2 h 
as indicated in the figures. The incubation medium was collected and subject to 
adiponectin ELISA.  
(I) Primary adipocytes were treated with or without 5 µg/ml BFA for 30 min and 
followed by 1 µg/ml insulin stimulation for 2 h. The incubation medium was 
collected and subjected to leptin ELISA. Bars and vertical lines indicate means ± 




3.5 PI3K-Akt but not MAPK pathway is involved in leptin secretion  
The above data suggest that insulin promotes leptin secretion through up 
regulating the constitutive pathway, so what are the signaling pathways through 
which insulin regulates leptin constitutive secretion? Several pathways have been 
proposed to be involved in insulin-stimulated leptin secretion, but it still remains 
controversial. There are conflicting reports showing the involvement of PI3K 
pathway in insulin-stimulated leptin secretion. Therefore, whether insulin-
stimulated leptin secretion in adipocytes was mediated by PI3K signaling was 
examined. 
 
3.5.1 Effect of PI3K-Akt inhibitors on leptin secretion 
Primary mouse white adipocytes were pretreated with wortmannin (100 
nM), a PI3K inhibitor, or DMSO for 30 min followed by insulin (1 µg/ml) 
treatment for 2 h to stimulate leptin secretion. In the presence of wortmannin, 
insulin-stimulated leptin secretion was significantly inhibited (1.10±0.07 fold 
compared to 1.34±0.05 fold in DMSO, n=10, p<0.01) without affecting basal 
leptin secretion (1.00±0.04 fold for DMSO and 0.94±0.04 fold for wortmannin, 
n=10, N.S.), suggesting the involvement of PI3K in insulin-stimulated leptin 
secretion (Fig. 8A).  
Next, whether PI3K downstream target Akt is involved in insulin-
stimulated leptin secretion was examined. The Akt1/2 inhibitor akti (10 µM) was 
used in place of wortmannin. Consistent with the above observation, akti (10 µM) 
significantly inhibited insulin-stimulated leptin secretion (1.06±0.07 fold 
compared to 1.27±0.05 fold, n=14, p<0.01) with no obvious effect on basal leptin 
secretion (1.00±0.04 fold for basal and 0.90±0.04 fold for akti, n=14, N.S.)(Fig.8 
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B). Therefore, the PI3K-Akt pathway is involved in insulin-stimulated leptin 
secretion in primary adipocytes. 
MAPK pathway was also reported to be involved in insulin-stimulated 
leptin secretion, so it was also examined in the present study. Primary adipocytes 
were incubated in the presence or absence of the MAPK inhibitor, PD98059 (50 
µM) prior to a 2 h insulin (1 µg/ml) exposure. With application of PD98059 (50 
µM), insulin-stimulated leptin secretion was modestly but not significantly lower 
as compared to control (1.19±0.04 fold compared to 1.29±0.07 fold, N.S. n=10) 
(Fig. 8C), although at this concentration, PD98059 effectively inhibited MAPK 
phosphorylation (Fig. 8D). Taken together, these data suggest that PI3K-Akt but 
not the MAPK pathway is involved in insulin-stimulated leptin secretion from 
primary white adipocytes. 
 
3.5.2 Insulin-stimulated leptin secretion is attenuated in DIO mice 
          To further confirm that insulin-PI3K-Akt pathway is involved in leptin 
secretion, it was investigated in insulin resistant adipocytes from DIO mice. The 
age-matched male mice were given HFD or chow diet from 7 weeks of age for 
the next 16 weeks. The body weight of HFD mice was significantly higher than 
that of control mice (37.06±1.89 g for control compared to 47.95±3.33 g for HFD, 
p<0.01, n=8) (Fig. 9A). In terms of body composition, the weight of fat in HFD 
mice was also higher than that in control mice (6.37±3.13 g for control compared 
to 18.61±2.30 g for HFD, p<0.01, n=8) (Fig. 9A). The phospho-Akt (serine 473) 
level in adipocytes isolated from HFD mice were significantly lower compared to 
that of control mice suggesting that these cells were insulin resistant (Fig. 9B).  
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 Plasma insulin increases upon feeding, so the plasma leptin levels in HFD 
and control mice after fasting and re-feeding was determined. The mice were 
fasted for 16 hours prior to determining the fasting plasma leptin level. 
Subsequently the mice were given food ad libitum and plasma leptin level was 
examined at 15, 30, 60, and 120 min after re-feeding. The fasting leptin level of 
HFD mice was almost 10 fold higher than that of control mice (5.95±3.51 ng/ml 
for control compared to 46.32±3.22 ng/ml for HFD, p<0.01, n=8). Plasma leptin 
level increased significantly after 120 min of feeding in control mice (5.95±3.51 
ng/m for fasting compared to 10.55± 3.43 for 120min, p<0.05, n=8). However 
there was no significant increase in plasma leptin level upon feeding even after 
120 min in HFD mice (46.32±3.22 ng/ml for fasting compared to 51.03±5.5 
ng/ml for 120min, N.S, n=8) suggesting that the leptin secretion induced by 
feeding was impaired in HFD mice (Fig. 9C).  
 To further confirm this, leptin secretion in primary adipocytes isolated 
from HFD and control mice was compared. The primary adipocytes were treated 
with or without insulin for 15, 30, 60, and 120 min to determine the changes in 
insulin-stimulated leptin secretion across time. The insulin-stimulated leptin 
concentration at each time point was normalized to basal leptin concentration at 
15 min. Insulin-stimulated leptin secretion was found to be significantly lower in 
adipocytes from HFD mice compared to that from control mice at 30, 60 and 120 
min (30 min: 1.26±0.05 fold for control vs. 1.10±0.02 fold for HFD, n=12, 
p<0.01; 60 min: 1.32±0.05 fold for control vs. 1.10± 0.02 fold for HFD, n=12, 
p<0.01; 120 min: 1.47±0.05 fold for control vs. 1.22±0.03 fold for HFD, n=12, 
p<0.01) (Fig. 9D), therefore strongly suggesting that insulin-stimulated leptin 









Figure 8 Effect of wortmannin, akti and PD98059 on leptin secretion 
Primary adipocytes were pretreated with PI3K inhibitor, 100 nM wortmannin (A), 
Akt1/2 inhibitor, 10 µM akti (B) or MAPK inhibitor, 50 µM PD98059 (C) for 30 
min and followed by 1 µg/m insulin treatment for 2 h. Bars and vertical lines 
indicate means±SE. **p< 0.01. (D) Representative immunoblot showing the 

















Figure 9 Insulin-stimulated leptin secretion  in HFD mice 
(A) Body weight and body composition of control and HFD mice. Bars and 
vertical lines indicate means±SE. **p<0.01. 
(B) Primary adipocytes isolated from control and HFD mice were treated with or 
without 1 µg/ml insulin for 30 min and the cell lysates were subjected to western 
blotting with Akt and phosho-Akt (serine 473)  antibodies.  
(C) Control (white square) and HFD (black square) mice were fasted overnight 
and blood was collected and referred as 0 min. The mice were fed with chow diet 
or HFD and the blood was collected at 15, 30, 60, and 120 min after feeding. The 
plasma collected was subjected to leptin ELISA. *p<0.05 
 (D) Primary adipocytes isolated from control (white square) and HFD (black 
square) mice were treated with or without 1 µg/ml insulin for 15, 30, 60 and 120 






3.6 Calcium is essential for insulin-stimulated leptin secretion by affecting 
Akt phosphorylation   
The role of calcium in insulin-stimulated leptin secretion remains poorly 
understood. From the observations in the present study, it is clear that calcium is 
required, but alone not sufficient to drive leptin release from isolated white 
adipocytes. Then calcium most probably exerts its role in signaling pathways 
involved in insulin-stimulated leptin secretion. Since it was shown that depletion 
of intracellular calcium had no inhibitory effect on the early steps of insulin 
actions, such as IR autophosphorylation, IRS-1 tyrosine phosphorylation, or 
activation of PI3K (Whitehead, Molero et al. 2001; Worrall and Olefsky 2002), 
the phosphorylation of Akt was examined in the absence of either extra- or 
intracellular calcium.  
Prmary adipocytes were incubated in calcium-free KRH buffer containing 
5 mM EGTA or BAPTA followed by 20 min insulin (1 µg/ml) stimulation. Cells 
were subsequently washed with calcium-free KRH buffer (without BSA), lysed, 
and immunoblotted for phospo-Akt (serine 473) and Akt. In the absence of 
extracellular calcium, Akt phosphorylation after insulin stimulation was 
significantly inhibited (Fig. 10A and 10B). Akt phosphorylation in primary 
adipocytes treated with BAPTA-AM (50 µM and 10 µM) or EGTA-AM (50 µM 
and 500 µM) was further examined. It was found that likewise, both BAPTA-
AM (50 µM) and EGTA-AM (500 µM) significantly inhibited Akt 
phosphorylation in primary white adipocytes (Fig. 10C and 10D). These data are 
consistent with a previous finding showing that intracellular calcium is a critical 
factor for Akt phosphorylation in 3T3-L1 cells. Taken together, these findings 
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provide a mechanism for how calcium is involved in insulin-stimulated leptin 






Figure 10 Effect of extra- and intracellular calcium chelaors on Akt 
phosphorylation 
Primary adipocytes were incubated with or without insulin (1 µg/ml) in KRH 
buffer containing 2.5mM calcium or 0 calcium plus 5mM EGTA (A) or BAPTA 
(B) for 2 h and the adipocytes were subsequently lysed and blotted using 
antibodies specific for phospho-Akt (serine 473) or Akt.  
Adipocytes were incubated for 30 min in the presence or absence of EGTA-AM 
(50 and 500 µM) (C) or BAPTA-AM (10 and 50 µM) (D) followed by treatment 
with insulin (1 µg/ml) for a further 20 min. These cells were lysed and blotted 


















In the present study, leptin has been shown to be stored in membrane-
bound secretory vesicles. These leptin-containing vesicles predominantly localize 
in the ER and PM. Disruption of Golgi apparatus impairs basal leptin secretion, 
therefore, together with the subcellular localization of leptin, it suggests that 
leptin-containing vesicles traffic in the classic ER-Golgi route. Insulin-stimulated 
leptin secretion is not regulated secretion as calcium influx alone is not sufficient 
for leptin secretion and insulin-stimulated leptin secretion depends on new 
protein synthesis. PI3K-Akt pathway was proved to be involved in insulin-
stimulated leptin secretion in vitro and in vivo. Calcium was found to be involved 
in insulin-stimulated leptin secretion because it was required for Akt 
phosphorylation.  
In this chapter, the significance of the two major findings that insulin 
increases leptin secretion through the PI3K-Akt pathway but not regulated 
secretion of leptin and the role of calcium in leptin secretion will be extensively 
discussed. A model for molecular control of leptin secretion will be proposed. 
 
4.1 Leptin-containing secretory vesicles go through the classic ER-Golgi 
route  
Here, it was demonstrated for the first time that leptin was packaged into 
membrane-bound vesicles in adipocytes by both bioimaging and biochemical 
approaches. Leptin appeared to be in punctate structure under TIRF microscope 
(Fig 2A), suggesting that part of leptin might be stored in small vesicles beneath 
PM. Previously, it was shown that leptin was in a honeycomb but not punctuate 
pattern in primary adipocytes using confocal microscopy (Barr, Malide et al. 
1997). In the present study, leptin likewise failed to show punctate staining under 
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confocal microscopy, which might be caused by the relative small size of the 
leptin-containing vesicles. In addition to the morphological study, leptin was also 
demonstrated to be protected from trypsin digestion in trypsin protection assay 
(Fig. 2B), which provided further evidence that leptin is packaged into 
membrane-bound vesicles.  
Not all the adipokines secreted by adipocytes are packaged into the 
membrane-bound vesicles. Some of them such as visfatin are secreted as soluble 
cytosol proteins. It was reported that visfatin was found in the cytosol fraction in 
subcellular fractionation and was digested when the cell lysate was treated with 
trypsin, suggesting that visfatin is not stored in membrane-bound secretory 
vesicles (Tanaka, Nozaki et al. 2007). This difference between leptin and visfatin 
suggests that adipocytes actively sort different secretory proteins into different 
types of carries to meet the need for function. 
By subcellular fractionation and immunofluorescent microscopy, it was 
shown here that leptin-containing vesicles localized predominantly in the ER, 
where leptin was synthesized and at PM where they are released, but not in Golgi 
(Fig. 3). A previous study (Roh, Thoidis et al. 2000) reported that leptin was 
enriched in HM and LM but not in PM. The discrepancy might be a result of 
differences in subcellular fractionation methods. In their fractionation, HM was 
enriched in ER but also contained PM, therefore, leptin in PM could be mostly 
fractioned into the HM instead of PM fraction. Results here are consistent with 
another group (Cammisotto, Bukowiecki et al. 2006) who reported the presence 
of immunogold-labeled leptin in RER and PM by electromicroscopy.  
The large amount of leptin accumulating in ER accounts for most of the 
intracellular leptin content. This ER pool of leptin remains significant (about 50% 
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of total) even after long time of CHX treatment (6 h) (Fig. 7B), which is different 
from normal constitutive secretion in which most of the intracellular secretory 
protein will be secreted after CHX treatment, suggesting that leptin secretion 
might be a novel form of secretion. The reason underlying the accumulation of 
leptin in ER is poorly understood. There is no KDEL sequence in leptin, however, 
leptin colocalized with KDEL suggesting that some ER resident proteins 
containing KDEL might be colocalized with leptin and could be involved in the 
accumulation of leptin in ER. Further investigation is needed to elucidate this. 
The function of this ER pool of leptin is also not well understood. It 
might account for the early effect (15-30 min) of insulin on leptin secretion. 
Since ER-Golgi transport is essential for insulin-stimulated leptin secretion 
(evidenced by BFA effect on insulin-stimulated leptin secretion), the early effect 
of insulin is most probably on ER-Golgi transport process. Upon insulin 
stimulation, leptin accumulated in ER may traffic to Golgi apparatus faster than 
basal status to make sure that there is more leptin to be secreted.  
There is also a small pool of leptin staying at PM which is neither 
responsible to insulin stimulation nor to calcium influx. It might be comprised of 
leptin-containing vesicles undergoing membrane fusion. Another possibility is 
that it might be a pool of leptin ready for other unknown stimulations which need 
further investigation. 
Localization of leptin with Golgi markers was not found in the present 
study (Fig. 3A and 3C), however, it was shown by others that leptin was 
detectable in Golgi by electromicroscopy (Cammisotto, Bukowiecki et al. 2006). 
Leptin-containing vesicles might transport through Golgi, as BFA blocked basal 
leptin secretion in my present study and prior ones (Cammisotto, Bukowiecki et 
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al. 2006). One possibility is that leptin-containing vesicles go through Golgi 
apparatus very rapidly such that no obvious accumulation could be detected by 
confocal microscopy. One piece of supportive evidence is that there is no 
consensus for N-linked glycosylation in leptin; therefore, it is possible that less 
time is needed for leptin to stay in Golgi apparatus for modification.  
In addition to the classic ER-Golgi secretory pathway, there are also non-
classic secretory pathways in which secretory proteins without signal peptide are 
secreted. In this kind of pathway, the secretory protein is not packaged into 
membrane-bound vesicles and the secretion is CHX and BFA insensitive (Nickel 
2005). In adipocytes, visfatin is secreted by this non-classic secretory pathway, 
suggesting that there are active sorting mechanisms in adipocytes to secret 
different adipokines. 
Thus, it is demonstrated here that membrane-bound leptin-containing 
vesicles are localized either in ER and or PM and they transport via the ER-Golgi 
secretory pathway without detectable accumulation of leptin in Golgi. 
 
4.2 Insulin-stimulated leptin secretion is not classic regulated secretion 
 There are conflicting reports regarding the secretory pathway that insulin-
stimulated leptin secretion goes through. Some reports suggest that insulin-
stimulated leptin secretion occurred through a regulated secretory pathway 
(Bradley and Cheatham 1999; Lee and Fried 2006), but others suggested that 
insulin-stimulated leptin secretion was not regulated secretion (Levy and Stevens 
2001; Turban, Hainault et al. 2001; Cammisotto, Bukowiecki et al. 2006). Our 
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results strongly suggest that insulin-stimulated leptin secretion is not regulated 
secretion based on the following evidences.  
  First, the secretion pattern of insulin-stimulated leptin secretion is not like 
that of regulated secretions. The basal leptin secretion increased with time and 
the insulin-stimulated leptin secretion was almost parallel to that of basal leptin 
secretion and there was no sudden rapid increase in leptin secretion upon insulin 
treatment (Fig. 4A). In addition, the insulin-stimulated secretion of leptin is 
modest (about 30%); therefore, the source of stimulated-leptin release is unlikely 
from preformed pools of leptin but rather increased secretion upon leptin 
synthesis. It was previously reported that leptin secretion from adipose tissue can 
be detected after 10 min of insulin stimulation (Barr, Malide et al. 1997). This 
corroborates with the current study, where insulin stimulates leptin secretion as 
early as 15 min, which is not long enough for protein synthesis. However, the 
secretion of leptin is delayed if compared to other fast vesicle trafficking such as 
Glut4 in adipocytes, which also suggests that the release of leptin might not be 
from a preformed pool of leptin. It remains possible that insulin increases the rate 
of vesicle trafficking along the ER-Golgi secretory pathway. 
Second, although both basal and insulin-stimulated leptin secretion is 
calcium dependent, the role of calcium in leptin secretion is different from that of 
neurotransmitter and polypeptide hormone release as the latter can be triggered 
by the calcium influx alone. In the calcium-induced protein exocytosis, the 
stimulators of the secretion lead to the opening of calcium channels and calcium 
influx which further triggers the membrane fusion process of the secretory 
granules from the preformed pool of granules and PM. In neurons, action 
potential opens Ca
2+
 channels, which leads to calcium influx. Calcium binds to 
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the two C2-domains of Syts and leads to the interaction of C2-domains with 
phospholipids and SNARE proteins and the subsequent membrane fusion 
(Sudhof 2012). In pancreatic β-cells, glucose metabolizes to generate ATP and 
leads to the closure of ATP-sensitive K
+
 channels (KATP) which in turn 
depolarize the PM and the voltage-dependent Ca
2+
 channels open (Fridlyand and 
Philipson 2011). Calcium binds to Syt7 and leads to the subsequent membrane 
fusion of insulin granules and PM (Gustavsson, Lao et al. 2008).  
 In mouse adipocytes, it is not known whether insulin leads to calcium 
influx, therefore, the effect of insulin on intracellular calcium concentration was 
examined. Ionomycin, an ionophore that leads to calcium influx is widely used in 
the research of calcium-induced protein exocytosis (Brandt, Pandol et al. 1991; 
Turner, Rennison et al. 1992; Blatchford, Hendry et al. 1995). Here, ionomycin 
efficiently raised the intracellular calcium concentration; on the contrary, insulin 
has no effect on intracellular calcium concentration (Fig. 6A and 6B). 
Furthermore, ionomycin was applied to raise the intracellular calcium 
concentration to see whether leptin secretion is inducible by calcium influx. 
Increase in intracellular calcium concentration alone is insufficient to induce 
leptin secretion (Fig. 6C), suggesting that calcium is not the trigger of membrane 
fusion of the leptin-containing vesicles to PM but through the other mechanisms.  
Third, insulin-stimulated leptin secretion depends on new protein 
synthesis. Insulin did not stimulate further leptin secretion after the basal leptin 
secretion was blocked by CHX (Fig. 7D), which is consistent with prior findings 
(Levy and Stevens 2001; Turban, Hainault et al. 2001; Cammisotto, Bukowiecki 
et al. 2006). Those reports showing that CHX cannot block insulin-stimulated 
leptin secretion were most likely due to the insufficient inhibition of the basal 
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leptin secretion. In this study, CHX almost totally inhibit the basal leptin 
secretion only after 4h of pre-treatment. It is noteworthy that effects of CHX can 
also be quickly reversed by removing it from the incubation medium. Therefore, 
there remains a possibility of insufficient protein synthesis inhibition by CHX 
before and during insulin treatment in these conflicting reports.  
 In addition, insulin-stimulated leptin secretion is BFA sensitive (Fig. 7I). 
BFA is a small hydrophobic compound produced by fungi that is widely used in 
the study of protein secretion. Within minutes of BFA treatment, the Golgi 
complex disassembles and redistributes into the ER, which makes BFA a potent 
inhibitor of secretion. BFA inhibits guanidyl nucleotide exchange factors that act 
on ARF-GTP binding proteins in the Golgi, which blocks the anterograde Golgi 
trafficking and causes the collapse of the Golgi stacks back into the ER (Tamura, 
Ando et al. 1968). In the present study, it was shown that after BFA treatment for 
30 min; insulin-stimulated leptin secretion was no longer detectable, suggesting 
that ER-Golgi trafficking of the leptin-containing vesicles is essential for insulin-
stimulated leptin secretion. 
Taken together, results here demonstrate that insulin can only modestly 
stimulate leptin secretion in short term and this secretion is not mediated by 
calcium influx. Furthermore, insulin-stimulated leptin secretion depends on new 
protein synthesis. Therefore, insulin-stimulated leptin secretion is not regulated 
secretion.  
The secretion induced by insulin or refeeding is modest and delayed as 
compare to other fast vesicle trafficking such as GLUT4 in adipocytes, because 
there is no preformed pool of leptin ready for release and it takes time for insulin 
to induce leptin production and secretion. It might be important for leptin to be 
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modulated in such way. First, this may explain why leptin plays its role in 
regulating energy homeostasis in a chronic manner but not acute way. Second, 
leptin also plays important role in the peripheral systems such as vascular system, 
immune system; therefore, it is critical to maintain a proper level of leptin in the 
serum. Dramatic fluctuation of leptin level in serum might affect the peripheral 
system functions. Third, insulin-stimulated leptin secretion might account for the 
correction of the decreased leptin level induced by leptin secretion inhibitors 
such as fasting and cold exposure to keep leptin at a proper level. Therefore, no 
acute and dramatic increase of leptin secretion is needed. 
Since insulin stimulates leptin secretion as early as 15 min and ER-Golgi 
trafficking is essential for insulin-stimulated leptin secretion, this relatively early 
action of insulin should be affecting the ER-Golgi trafficking but not 
translational regulation. After the early effect, insulin might promote leptin 
protein synthesis at the level of translation as mRNA level of leptin is not altered 
by insulin within 2 h. 
 
4.3 The involvement of PI3K-Akt pathway in insulin-stimulated leptin 
secretion 
There are conflicting reports on the signaling pathways involved in 
insulin-stimulated leptin secretion. One group showed that treatment of PI3K 
inhibitor LY294002 inhibited the insulin-stimulated leptin secretion from 
primary adipocytes (Bradley and Cheatham 1999). However, another group 
reported that wortmannin, another PI3K inhibitor did not inhibit insulin-
stimulated leptin secretion in 3T3-L1 adipocytes (Zeigerer, Rodeheffer et al. 
2008). It was found here that wortmannin blocked the insulin-stimulated leptin in 
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primary mouse adipocytes (Fig. 8A), which is consistent with Bradley and co-
workers. The discrepancy might be caused by the different cell types used 
(primary vs. 3T3-L1 adipocytes). Furthermore, it was demonstrated here that 
Akt1/2 inhibitor akti had the similar inhibitory effect on insulin-stimulated leptin 
secretion without affecting basal leptin secretion (Fig. 8B). To further confirm 
the involvement of PI3K-Akt pathway, the insulin-stimulated leptin secretion in 
DIO mice was examined in vivo and in vitro. The PI3K-Akt pathway in these 
mice was impaired as the phosphorylation of Akt in adipocytes decreased 
dramatically (Fig. 9B). As expected, the leptin secretion induced by re-feeding 
after fasting was significantly impaired in these insulin-resistant DIO mice (Fig. 
9C). Furthermore, the insulin-stimulated leptin secretion in the primary 
adipocytes isolated from these DIO mice also decreased compared to control diet, 
non-obese mice (Fig. 9D). It was also reported that in Akt KO mouse, there was 
less fat compared to WT mouse and the leptin level was also low (Chen, Peng et 
al. 2009). Hence, the PI3K-Akt pathway is a prime candidate for mediating the 
insulin-stimulated leptin secretion. 
 The PI3K-Akt pathway might be involved in leptin secretion in several 
aspects. As shown here, insulin-stimulated leptin secretion depends on protein 
synthesis and the PI3K-Akt pathway may mediate the effect of insulin on leptin 
protein synthesis through activating mTOR activity. PI3k-Akt-mTOR pathway is 
a well-established pathway for protein synthesis (Scott, Brunn et al. 1998). In 
addition, it was reported that inhibition of mTOR activity leads to decreased 
insulin-stimulated leptin secretion (Bradley and Cheatham 1999), hence mTOR 
could be the downstream target of Akt in regulating leptin secretion. Other 
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substrates of Akt could also be required for insulin-stimulated leptin protein 
synthesis and further investigation is needed to find out the potential candidates. 
PI3K-Akt might also be involved in leptin secretion through other 
mechanisms. From the findings here, insulin increases leptin secretion as early as 
15 min. In such short time, de novo protein synthesis may not be accomplished, 
so it is possible that insulin modulates leptin secretory vesicle trafficking through 
PI3K-Akt pathway. It is previously reported that PI3K-Akt pathway plays critical 
roles in GLUT4 vesicles translocation in adipocytes (Lopez, Burchfield et al. 
2009). Whether a similar mechanism occurs with leptin in the adipocytes remains 
to be investigated.  
 
4.6 Calcium is required for insulin-stimulated Akt phosphhorylation and 
subsequent leptin secretion 
The role of calcium in insulin-stimulated leptin secretion is also not well 
established. Previously, Levy and colleagues reported that treatment with 
BAPTA-AM decreased the insulin-stimulated leptin secretion, but the 
mechanism was not provided (Levy, Gyarmati et al. 2000). Cammisotto and 
coworkers showed that insulin-stimulated leptin secretion was inhibited in the 
absence of extracellular calcium only because of the inhibitory effect of depletion 
of calcium on glucose uptake and had no effect on the leptin synthesis and 
secretion per se (Cammisotto and Bukowiecki 2004). Here, it was shown that 
insulin-stimulated leptin secretion depends on calcium, because calcium is 
required for the robust phosphorylation of Akt upon insulin stimulation (Fig.10). 
Since the phosphorylation of Akt depends on calcium, a mechanism that allows 
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for a cross-talk between calcium influx and downstream insulin signaling must 
exist in isolated white adipocytes. Calcium might affect the Akt phosphorylation 
through calmodulin, as W13, a calmodulin inhibitor decreased the Akt 
phosphorylation in 3T3-L1 cells (Whitehead, Molero et al. 2001). Another 
calmodulin inhibitor, W-7, was shown to block the Akt phosphorylation in breast 
cancer cell line (Coticchia, Revankar et al. 2009). In addition, a loss of 
intracellular calcium may also affect the translocation of Akt to cell membrane 
thereby preventing its phosphorylation (Worrall and Olefsky 2002). Whether or 
not these mechanisms occur in the adipocytes is subjected to further investigation.  
4.4 Calcium is required for basal leptin secretion 
The precise role of calcium in both basal and insulin-stimulated leptin 
secretion in primary adipocytes remains unclear. Previous studies have shown 
that both extra- and intracellular calcium was important for insulin-stimulated but 
not basal leptin secretion (Levy, Gyarmati et al. 2000; Cammisotto and 
Bukowiecki 2004). In contrast, the evidence presented here suggests that basal 
leptin secretion is also decreased in the absence of either extra- or intracellular 
calcium (Fig. 5).  
Basal leptin concentration is correlated with the percentage of body fat 
and is elevated in obese patients. However, after weight loss, the declined serum 
leptin level increased again even though a lower weight was maintained in these 
patients (Considine, Sinha et al. 1996). Therefore, endogenous regulators other 
than fat mass might control basal leptin levels in these patients. One of these 
regulators might be intracellular calcium, and similar to type 2 diabetic patients 
(Jeremy, Gill et al. 1995; Levy 1999), the increased basal leptin secretion in 
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obese patients may be partially attributed to the abnormal adipocytes calcium 
homeostasis.  
There are at least three potential mechanisms for controlling of basal 
leptin level by calcium. First, calcium might be required for the protein synthesis 
process of leptin from adipocytes. Kockx and colleague reported that BAPTA-
AM inhibited the general protein synthesis in macrophages, which may be 
responsible partially for the inhibitory effect of BAPTA-AM on basal ApoE 
secretion from macrophages (Kockx, Guo et al. 2007). Similarly, calcium might 
also be needed for leptin protein synthesis.  
Second, calcium might be involved in the leptin-containing vesicle 
trafficking process. Calcium plays important role in neurotransmitter (Martens, 
Kozlov et al. 2007) and polypeptide hormone (MacDonald, Eliasson et al. 2005) 
vesicle trafficking processes. It has been reported that calcium is required for ER-
Golgi trafficking (Beckers and Balch 1989) and intra-Golgi transport (Porat and 
Elazar 2000). Therefore, it is possible that calcium plays a similar role in leptin-
containing vesicles trafficking along the secretory pathway in adipocytes. 
Cytoskeleton is essential for protein exocytosis as it helps the protein trafficking 
process. It has been reported that F-actin network near the PM acts as a barrier to 
protein exocytosis and that calcium directly controls the cytoskeletal changes 
(Yoneda, Nishizaki et al. 2000). In adipocytes, it is still unknown whether actin 
network is involved in leptin secretion, therefore, further investigation is needed 
to see whether calcium affects leptin-containing trafficking through affecting 
actin network.  
Third, calcium might exert its role in basal leptin secretion by acting on 
the leptin-containing vesicles membrane fusion process.  It has been 
106 
 
demonstrated that in the presence of Ca
2+
, target SNAREs on PM and vesicular 
SNARE on secretory vesicles interact and self-assemble in a circular pattern to 
form conducting channels so that membrane fusion process is accomplished 
(Jena 2009). Further studies are needed to show whether leptin-containing 
vesicles also undergo such process. 
 
 
4.7 A proposed working model for molecular control of leptin secretion  
Based on the data of the present study, a working model for leptin 
secretin is proposed here. At basal status, leptin is synthesized in RER and a 
large amount of leptin is accumulated at ER to make up a pool of leptin in ER. 
Some of the leptin in ER is transported to Golgi and pass Golgi in very short time. 
After budding from Golgi, leptin-containing vesicles constitutively go to PM and 
fuse with PM to release leptin. Calcium is required in this process.  
Upon insulin stimulation, insulin binds to IR and triggers the PI3K-Akt 
pathway and leads to the increase in leptin secretion. Leptin trafficking from ER 
to Golgi is first accelerated by insulin within minutes, and later on, leptin protein 
synthesis is increased which leads to the continuous increase in leptin secretion. 
Calcium is required for insulin-stimulated Akt phosphorylation. 
 
4.8 Conclusions 
Leptin is mainly secreted by the constitutive secretion and insulin 
increases leptin release from white adipocytes through the PI3K-Akt pathway. 




4.9 Remaining questions 
4.9.1 How does extracellular calium affect Akt phosphorylation? 
Unexpectedly, the absence of extracellular calcium also leads to the 
decreased Akt phosphorylation. Previously, it was shown that EGTA had no 
inhibitory effect on the EGF induced Akt phosphorylation in mouse mammary 
carcinoma cells (Deb, Coticchia et al. 2004). To elucidate the molecules 
mediating the effect of extracellular calcium on Akt phosphorylation, some 
potential candidates were examined.  
         In adipocytes, extracellular calcium signals into the cells via several 
molecules including calcium sensing receptor (CaSR) (Hofer and Brown 2003), 
transient receptor potential cation channel (TRPC)1, TRPC4, TRPC6 (Hu, He et 
al. 2009), and calcium sensor Syt7 (Li, Wang et al. 2007). Therefore, the effect 
of CaSR antagonist NPS-2390 (NPS) (50 µM) and TRPC6 blocker SKF96365 
(SKF) (50 µM) on leptin secretion and Akt phosphorylation were examined in 
primary adipocytes.  
          Primary adipocytes were pretreated with NPS (50 µM) and SKF (50 µM) 
for 30 min and followed by insulin (1 µg/ml) treatment for 2 h. The incubation 
medium was collected for leptin ELISA and the adipocytes were washed in BSA 
free KRH buffer and lysed for western blot analysis. It was found that both 
blockers had no effect on either basal (1±0.03 fold for vehicle, n=7; 0.88±0.03 
fold for SKF, n=5; 0.93±0.02 fold for NPS, n=6, N.S.) or insulin-stimulated 
leptin secretion (1.19±0.06 fold for insulin, n=5; 1.12±0.04 fold for SKF+insulin, 
n=7; 1.19±0.03 fold for NPS+insulin, n=8; N.S.) (Fig.11A). Akt phosphorylation 
was also not inhibited by either of the blockers (Fig. 11B). Thus, the CaSR and 
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TRPC6 are not likely to mediate the effect of extracellular calcium on Akt 
phosphorylation 
        Syt7 is one of the calcium sensors that are critical for hormone secretion 
such as insulin, glucagon and glucagon like peptide 1 (GLP1) (Gustavsson, Lao 
et al. 2008; Gustavsson, Wei et al. 2009; Gustavsson, Wang et al. 2011). In 
addition, Syt7 was also shown to be important for GLUT4 trafficking in 
adipocytes (Li, Wang et al. 2007), suggesting that Syt7 might mediate the 
granules trafficking in adipocytes. Therefore, the role of Syt7 in leptin secretion 
in primary adipocytes was studied. Primary adipocytes were isolated from WT 
and Syt7 KO mice and treated with or without insulin (1 µg/ml) for 2 h. After the 
stimulation, the incubation medium was collected for leptin ELISA 
measurements. It turned out that adipocytes from Syt7 KO mice secreted leptin in 
the same manner as those from wt mice upon insulin stimulation (WT: 1±0.05 
fold for basal, n=8; 1.40±0.13 fold for insulin, n=8, p<0.05; KO: 1±0.05 fold for 
basal, n=10; 1.35±0.10 fold for insulin, n=10, p<0.05) (Fig. 11C). Thus, Syt 7 is 
not involved in the extracellular calcium dependence of leptin secreion. 
Together, the molecules investigated here namely the CaSR, TRPC6 and 
Syt7 are all not involved in it. The mechanism underlying the inhibitory effect of 







Figure 11 Effect of NPS, SKF and Syt 7 KO on leptin secretion 
(A) Primary adipocytes were pretreated with CaSR antagonist NPS (50 µM) or 
TRPC6 blocker SKF (50 µM) for 30 min and followed by 1 µg/m insulin 
treatment for 2 h. The incubation medium was collected for leptin measurement 
by ELISA.  
(B) Representative western blot showing the effect of NPS (50 µM) and SKF (50 
µM) on the phosphorylation of Akt in primary adipocytes.  
(C) Primary adipocytes isolated from WT and Sy7 KO mice were incubated with 








4.9.2 How does insulin stimulate leptin secretion within minutes? 
It has been shown here that insulin increases leptin secretion as fast as 15-
30 min which is not long enough for protein synthesis. In addition, there is no 
preformed pool of leptin that is responsible for insulin stimulation. Then how 
does insulin promote the leptin secretion in such a short time? Is the PI3K-Akt 
pathway also involved? One possibility is that insulin might affect the leptin-
containing compartment trafficking from ER to Golgi. In mammalian cells, cargo 
moves from the ER to Golgi in carriers that travel along microtubules (Presley, 
Cole et al. 1997). It has been reported that insulin could induce polymerization of 
microtubules in a PI3K independent manner and lead to GLUT4 translocation in 
3T3-L1 adipocytes (Olson, Eyster et al. 2003). Therefore, it is possible that 
insulin also promote the leptin transport from ER to Golgi by affecting 
microtubules. The involvement of microtubules in leptin secretion needs to be 
investigated. 
 
4.9.3 Is cytoskeleton involved in leptin-containing vesicles trafficking ? 
After budding from the TGN, both regulated and constitutive secretory 
vesicles are transported along the microtubule-based transport system (Goldstein and 
Yang 2000; Rudolf, Salm et al. 2001). At the end of the microtubule network, 
secretory vesicles are shifted to the actin cortex near the PM with the help of F-actin 
motor protein (Brown, Peacock-Villada et al. 2002). It has been reported that F-actin 
near PM acts as a cortical barrier for dense-core secretory granules in the regulated 
secretion in chromaffin and mast cells (Norman, Price et al. 1994); (Vitale, Rodriguez 
Del Castillo et al. 1992). In contrast to the regulated secretory pathway, there is 
controversial evidence for the involvement of actin in the constitutive secretory 
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pathway in mammalian cells. Some group reported that F-actin disruption failed to 
affect constitutive secretion in epithelial cells (Salas, Misek et al. 1986). However, 
another group showed that latrunculin B (LanB), which depolymerizes F-actin, 
promoted constitutive secretion in Glial cells. The effect of LanB on constitutive 
leptin secretion was also examined here and it turned out to inhibit basal leptin 
secretion (Fig. 12), suggesting that actin polymerization is essential for leptin 
secretion. The reverse effect of actin network on leptin secretion suggests it to be a 
different form than other constitutive secretion. Further investigation is needed to 







Figure 12 Effect of LanB on constitutive leptin secretion 
Primary adipocytes were treated with (black square) or without (white square) 5 
µM of LanB for 15, 30, 60 and 120 min. The incubation medium was collected 
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